NewsController
Controller
path |
/controllers/NewsController.php |
abs_path |
/var/www/lbofrance.com/docs/wp-content/themes/yagami/controllers/NewsController.php |
Render
view |
views/news/single.twig |
Datas
array:1 [
"post" => Post {#7022
+ImageClass: "Timber\Image"
+PostClass: "Timber\Post"
+TermClass: "Timber\Term"
+object_type: "post"
+custom: array:16 [
"_wpml_word_count" => "{"total":0,"to_translate":{"en":2,"fr":2,"it":2}}"
"_edit_lock" => "1622729707:2"
"_edit_last" => "2"
"_wpml_media_duplicate" => "1"
"_wpml_media_featured" => "1"
"_last_translation_edit_mode" => "native-editor"
"_yoast_wpseo_content_score" => "30"
"_yoast_wpseo_estimated-reading-time-minutes" => "3"
"banner" => ""
"_banner" => "field_5d0b8f67a8a14"
"linkedin" => ""
"_linkedin" => "field_5d0b8fa0a8a15"
"fichier" => "5479"
"_fichier" => "field_5d0b8faba8a16"
"_yoast_wpseo_primary_category" => "32"
"_wpml_media_has_media" => "1"
]
#___content: """
<p>Press Release</p>\n
<p>New York, NY, June 3, 2021</p>\n
<p> </p>\n
<p><strong>Antidote Raises $23 Million to Scale Digital Patient Engagement Services</strong></p>\n
<p><strong> </strong><strong>The funding, led by LBO France, will be used to enhance Antidote’s platform and accelerate new data products, connecting patients to research globally.</strong></p>\n
<p> </p>\n
<p><strong>New York, NY June 3, 2021</strong> — Antidote Technologies Limited (“Antidote”) today announced it has closed $23.2 million in funding to expand its digital patient engagement programs and clinical trial recruitment services. The funding round was led by LBO France, a private equity firm committed to supporting the growth of digital health, both in transforming health systems and accelerating medical R&D.</p>\n
<p>Through its Digital Health 2 fund, LBO France is investing $10 million, joining existing major investors Merck Global Health Innovation Fund, Smedvig Capital, and Octopus Ventures, who between them are investing $13.2 million. Sebastien Woynar and Franck Noiret of LBO France will join the Antidote Board as a director and an observer, respectively.</p>\n
<p> </p>\n
<p>“The importance of clinical research has never been more clear than in the past year, as the industry stepped up to develop treatments and vaccines faster than could ever have been imagined,” said <strong>Laurent Schockmel, CEO of Antidote</strong>. “But despite the speed of response to Covid-19, some 80% of clinical trials are still delayed or closed due to a lack of participants. We welcome LBO France as a partner to help us achieve our mission of transforming the way that researchers and patients connect in an effort to accelerate medical research.”</p>\n
<p> </p>\n
<p>This new round of funding will allow the company to build on recent commercial success and accelerate growth. In 2020, Antidote increased its annual revenue by 66% and the number of projects handled by 158% over the previous year. In the first quarter of 2021 alone, the company surpassed its entire 2020 revenue.</p>\n
<p>In concert with its extensive partner network of patient advocacy groups, Antidote operates with a truly patient-centric approach, balancing technology with a human touch. The funding will be used to enhance its clinical trial search engine, launch new products and services (including data insights), and expand its footprint internationally.</p>\n
<p> </p>\n
<p>“Antidote is a company in high-growth mode aiming to solve one of the most difficult problems of clinical research — connecting patients to trials,” said <strong>Sebastien Woynar</strong>, <strong>Investment Director at LBO France</strong>, “We’re excited to invest in an impressive team and a business that aligns so well with our investment objectives, to support their important mission.”</p>\n
<p> </p>\n
<p><strong>Franck Noiret, Managing Director at LBO France</strong>, added “We believe that Antidote, as the fifth investment of our Digital Health 2 fund, will greatly benefit from our sectoral expertise and significant experience in the field of clinical trials.”</p>\n
<p> </p>\n
<p>Antidote understands that solving the problem of clinical trial patient recruitment will require innovative solutions to help willing and interested patients find, screen for, and enroll in medical research. With this new round of funding, the company will continue to lead the field in delivering such solutions. To learn more about Antidote’s work to accelerate medical research, please <a href="https://www.antidote.me/researchers/contact">get in touch</a>.</p>\n
"""
#_permalink: "https://www.lbofrance.com/en/lbo-frances-digital-health-team-leads-a-23-million-growth-round-in-antidote/"
#_next: []
#_prev: []
#_css_class: null
+id: 5478
+ID: 5478
+post_author: "2"
+post_content: """
Press Release\r\n
\r\n
New York, NY, June 3, 2021\r\n
\r\n
\r\n
\r\n
<strong>Antidote Raises $23 Million to Scale Digital Patient Engagement Services</strong>\r\n
\r\n
<strong> </strong><strong>The funding, led by LBO France, will be used to enhance Antidote’s platform and accelerate new data products, connecting patients to research globally.</strong>\r\n
\r\n
\r\n
\r\n
<strong>New York, NY June 3, 2021</strong> — Antidote Technologies Limited (“Antidote”) today announced it has closed $23.2 million in funding to expand its digital patient engagement programs and clinical trial recruitment services. The funding round was led by LBO France, a private equity firm committed to supporting the growth of digital health, both in transforming health systems and accelerating medical R&D.\r\n
\r\n
Through its Digital Health 2 fund, LBO France is investing $10 million, joining existing major investors Merck Global Health Innovation Fund, Smedvig Capital, and Octopus Ventures, who between them are investing $13.2 million. Sebastien Woynar and Franck Noiret of LBO France will join the Antidote Board as a director and an observer, respectively.\r\n
\r\n
\r\n
\r\n
“The importance of clinical research has never been more clear than in the past year, as the industry stepped up to develop treatments and vaccines faster than could ever have been imagined,” said <strong>Laurent Schockmel, CEO of Antidote</strong>. “But despite the speed of response to Covid-19, some 80% of clinical trials are still delayed or closed due to a lack of participants. We welcome LBO France as a partner to help us achieve our mission of transforming the way that researchers and patients connect in an effort to accelerate medical research.”\r\n
\r\n
\r\n
\r\n
This new round of funding will allow the company to build on recent commercial success and accelerate growth. In 2020, Antidote increased its annual revenue by 66% and the number of projects handled by 158% over the previous year. In the first quarter of 2021 alone, the company surpassed its entire 2020 revenue.\r\n
\r\n
In concert with its extensive partner network of patient advocacy groups, Antidote operates with a truly patient-centric approach, balancing technology with a human touch. The funding will be used to enhance its clinical trial search engine, launch new products and services (including data insights), and expand its footprint internationally.\r\n
\r\n
\r\n
\r\n
“Antidote is a company in high-growth mode aiming to solve one of the most difficult problems of clinical research — connecting patients to trials,” said <strong>Sebastien Woynar</strong>, <strong>Investment Director at LBO France</strong>, “We’re excited to invest in an impressive team and a business that aligns so well with our investment objectives, to support their important mission.”\r\n
\r\n
\r\n
\r\n
<strong>Franck Noiret, Managing Director at LBO France</strong>, added “We believe that Antidote, as the fifth investment of our Digital Health 2 fund, will greatly benefit from our sectoral expertise and significant experience in the field of clinical trials.”\r\n
\r\n
\r\n
\r\n
Antidote understands that solving the problem of clinical trial patient recruitment will require innovative solutions to help willing and interested patients find, screen for, and enroll in medical research. With this new round of funding, the company will continue to lead the field in delivering such solutions. To learn more about Antidote’s work to accelerate medical research, please <a href="https://www.antidote.me/researchers/contact">get in touch</a>.
"""
+post_date: "2021-06-03 16:15:57"
+post_excerpt: ""
+post_parent: 0
+post_status: "publish"
+post_title: "LBO France’s Digital Health team leads a $23 million growth round in Antidote"
+post_type: "post"
+slug: "lbo-frances-digital-health-team-leads-a-23-million-growth-round-in-antidote"
#__type: null
+"_wpml_word_count": "{"total":0,"to_translate":{"en":2,"fr":2,"it":2}}"
+"_edit_lock": "1622729707:2"
+"_edit_last": "2"
+"_wpml_media_duplicate": "1"
+"_wpml_media_featured": "1"
+"_last_translation_edit_mode": "native-editor"
+"_yoast_wpseo_content_score": "30"
+"_yoast_wpseo_estimated-reading-time-minutes": "3"
+"banner": ""
+"_banner": "field_5d0b8f67a8a14"
+"linkedin": ""
+"_linkedin": "field_5d0b8fa0a8a15"
+"fichier": "5479"
+"_fichier": "field_5d0b8faba8a16"
+"_yoast_wpseo_primary_category": "32"
+"_wpml_media_has_media": "1"
+"post_date_gmt": "2021-06-03 14:15:57"
+"comment_status": "open"
+"ping_status": "closed"
+"post_password": ""
+"post_name": "lbo-frances-digital-health-team-leads-a-23-million-growth-round-in-antidote"
+"to_ping": ""
+"pinged": ""
+"post_modified": "2021-06-03 16:17:28"
+"post_modified_gmt": "2021-06-03 14:17:28"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/?p=5478"
+"menu_order": 0
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"status": "publish"
+"partial_banner_title": false
+"partial_banner_image": false
}
]
TimberPost
ID:
5478
post_type:
post
slug:
lbo-frances-digital-health-team-leads-a-23-million-growth-round-in-antidote
post_name:
lbo-frances-digital-health-team-leads-a-23-million-growth-round-in-antidote
post_title:
LBO France’s Digital Health team leads a $23 million growth round in Antidote
array:54 [
"ImageClass" => "Timber\Image"
"PostClass" => "Timber\Post"
"TermClass" => "Timber\Term"
"object_type" => "post"
"custom" => array:16 [
"_wpml_word_count" => "{"total":0,"to_translate":{"en":2,"fr":2,"it":2}}"
"_edit_lock" => "1622729707:2"
"_edit_last" => "2"
"_wpml_media_duplicate" => "1"
"_wpml_media_featured" => "1"
"_last_translation_edit_mode" => "native-editor"
"_yoast_wpseo_content_score" => "30"
"_yoast_wpseo_estimated-reading-time-minutes" => "3"
"banner" => ""
"_banner" => "field_5d0b8f67a8a14"
"linkedin" => ""
"_linkedin" => "field_5d0b8fa0a8a15"
"fichier" => "5479"
"_fichier" => "field_5d0b8faba8a16"
"_yoast_wpseo_primary_category" => "32"
"_wpml_media_has_media" => "1"
]
"\x00*\x00___content" => null
"\x00*\x00_permalink" => null
"\x00*\x00_next" => []
"\x00*\x00_prev" => []
"\x00*\x00_css_class" => null
"id" => 5478
"ID" => 5478
"post_author" => "2"
"post_content" => """
Press Release\r\n
\r\n
New York, NY, June 3, 2021\r\n
\r\n
\r\n
\r\n
<strong>Antidote Raises $23 Million to Scale Digital Patient Engagement Services</strong>\r\n
\r\n
<strong> </strong><strong>The funding, led by LBO France, will be used to enhance Antidote’s platform and accelerate new data products, connecting patients to research globally.</strong>\r\n
\r\n
\r\n
\r\n
<strong>New York, NY June 3, 2021</strong> — Antidote Technologies Limited (“Antidote”) today announced it has closed $23.2 million in funding to expand its digital patient engagement programs and clinical trial recruitment services. The funding round was led by LBO France, a private equity firm committed to supporting the growth of digital health, both in transforming health systems and accelerating medical R&D.\r\n
\r\n
Through its Digital Health 2 fund, LBO France is investing $10 million, joining existing major investors Merck Global Health Innovation Fund, Smedvig Capital, and Octopus Ventures, who between them are investing $13.2 million. Sebastien Woynar and Franck Noiret of LBO France will join the Antidote Board as a director and an observer, respectively.\r\n
\r\n
\r\n
\r\n
“The importance of clinical research has never been more clear than in the past year, as the industry stepped up to develop treatments and vaccines faster than could ever have been imagined,” said <strong>Laurent Schockmel, CEO of Antidote</strong>. “But despite the speed of response to Covid-19, some 80% of clinical trials are still delayed or closed due to a lack of participants. We welcome LBO France as a partner to help us achieve our mission of transforming the way that researchers and patients connect in an effort to accelerate medical research.”\r\n
\r\n
\r\n
\r\n
This new round of funding will allow the company to build on recent commercial success and accelerate growth. In 2020, Antidote increased its annual revenue by 66% and the number of projects handled by 158% over the previous year. In the first quarter of 2021 alone, the company surpassed its entire 2020 revenue.\r\n
\r\n
In concert with its extensive partner network of patient advocacy groups, Antidote operates with a truly patient-centric approach, balancing technology with a human touch. The funding will be used to enhance its clinical trial search engine, launch new products and services (including data insights), and expand its footprint internationally.\r\n
\r\n
\r\n
\r\n
“Antidote is a company in high-growth mode aiming to solve one of the most difficult problems of clinical research — connecting patients to trials,” said <strong>Sebastien Woynar</strong>, <strong>Investment Director at LBO France</strong>, “We’re excited to invest in an impressive team and a business that aligns so well with our investment objectives, to support their important mission.”\r\n
\r\n
\r\n
\r\n
<strong>Franck Noiret, Managing Director at LBO France</strong>, added “We believe that Antidote, as the fifth investment of our Digital Health 2 fund, will greatly benefit from our sectoral expertise and significant experience in the field of clinical trials.”\r\n
\r\n
\r\n
\r\n
Antidote understands that solving the problem of clinical trial patient recruitment will require innovative solutions to help willing and interested patients find, screen for, and enroll in medical research. With this new round of funding, the company will continue to lead the field in delivering such solutions. To learn more about Antidote’s work to accelerate medical research, please <a href="https://www.antidote.me/researchers/contact">get in touch</a>.
"""
"post_date" => "2021-06-03 16:15:57"
"post_excerpt" => ""
"post_parent" => 0
"post_status" => "publish"
"post_title" => "LBO France’s Digital Health team leads a $23 million growth round in Antidote"
"post_type" => "post"
"slug" => "lbo-frances-digital-health-team-leads-a-23-million-growth-round-in-antidote"
"\x00*\x00__type" => null
"_wpml_word_count" => "{"total":0,"to_translate":{"en":2,"fr":2,"it":2}}"
"_edit_lock" => "1622729707:2"
"_edit_last" => "2"
"_wpml_media_duplicate" => "1"
"_wpml_media_featured" => "1"
"_last_translation_edit_mode" => "native-editor"
"_yoast_wpseo_content_score" => "30"
"_yoast_wpseo_estimated-reading-time-minutes" => "3"
"banner" => ""
"_banner" => "field_5d0b8f67a8a14"
"linkedin" => ""
"_linkedin" => "field_5d0b8fa0a8a15"
"fichier" => "5479"
"_fichier" => "field_5d0b8faba8a16"
"_yoast_wpseo_primary_category" => "32"
"_wpml_media_has_media" => "1"
"post_date_gmt" => "2021-06-03 14:15:57"
"comment_status" => "open"
"ping_status" => "closed"
"post_password" => ""
"post_name" => "lbo-frances-digital-health-team-leads-a-23-million-growth-round-in-antidote"
"to_ping" => ""
"pinged" => ""
"post_modified" => "2021-06-03 16:17:28"
"post_modified_gmt" => "2021-06-03 14:17:28"
"post_content_filtered" => ""
"guid" => "https://www.lbofrance.com/?p=5478"
"menu_order" => 0
"post_mime_type" => ""
"comment_count" => "0"
"filter" => "raw"
"status" => "publish"
]
Timber Context
Base Context
array:10 [
"http_host" => "https://www.lbofrance.com"
"wp_title" => "LBO France’s Digital Health team leads a $23 million growth round in Antidote - LBO France"
"body_class" => "post-template-default single single-post postid-5478 single-format-standard"
"site" => Site {#7064
+admin_email: "admin@adveris.fr"
+blogname: null
+charset: "UTF-8"
+description: ""
+id: null
+language: "en_US"
+multisite: false
+name: "LBO France"
+pingback_url: "https://www.lbofrance.com/xmlrpc.php"
+siteurl: null
+theme: Theme {#7037
+name: "Yagami"
+version: ""
+parent: false
+parent_slug: null
+slug: "yagami"
+uri: "https://www.lbofrance.com/wp-content/themes/yagami"
-theme: WP_Theme {#7039
+update: false
-theme_root: "/var/www/lbofrance.com/docs/wp-content/themes"
-headers: array:14 [
"Name" => "Yagami"
"ThemeURI" => ""
"Description" => "Custom starter to build wordpress theme from scratch"
"Author" => "Kévin Vacherot"
"AuthorURI" => "https://www.linkedin.com/in/k%C3%A9vin-vacherot-b9a004a2/"
"Version" => ""
"Template" => ""
"Status" => ""
"Tags" => "yagami, blank"
"TextDomain" => "Yagami"
"DomainPath" => ""
"RequiresWP" => ""
"RequiresPHP" => ""
"UpdateURI" => ""
]
-headers_sanitized: array:2 [
"Name" => "Yagami"
"Version" => ""
]
-block_theme: false
-name_translated: null
-errors: null
-stylesheet: "yagami"
-template: "yagami"
-parent: null
-theme_root_uri: "https://www.lbofrance.com/wp-content/themes"
-textdomain_loaded: null
-cache_hash: "37a7699c69410d0bf18f875580b71453"
}
+id: null
+ID: null
+object_type: null
}
+title: "LBO France"
+url: "https://www.lbofrance.com/en/"
+home_url: "https://www.lbofrance.com/en/"
+site_url: "https://www.lbofrance.com"
+rdf: "https://www.lbofrance.com/en/feed/rdf/"
+rss: "https://www.lbofrance.com/en/feed/rss/"
+rss2: "https://www.lbofrance.com/en/feed/"
+atom: "https://www.lbofrance.com/en/feed/atom/"
+ID: null
+object_type: null
+"pingback": "https://www.lbofrance.com/xmlrpc.php"
}
"request" => Request {#7038
+post: []
+get: []
+id: null
+ID: null
+object_type: null
}
"user" => false
"theme" => Theme {#7037}
"posts" => PostQuery {#7035
+found_posts: 1
#userQuery: false
#queryIterator: QueryIterator {#7034
-_query: WP_Query {#4911
+query: array:2 [
"page" => ""
"name" => "lbo-frances-digital-health-team-leads-a-23-million-growth-round-in-antidote"
]
+query_vars: array:67 [
"page" => 0
"error" => ""
"m" => ""
"p" => 5478
"post_parent" => ""
"subpost" => ""
"subpost_id" => ""
"attachment" => ""
"attachment_id" => 0
"pagename" => ""
"page_id" => ""
"second" => ""
"minute" => ""
"hour" => ""
"day" => 0
"monthnum" => 0
"year" => 0
"w" => 0
"category_name" => ""
"tag" => ""
"cat" => ""
"tag_id" => ""
"author" => ""
"author_name" => ""
"feed" => ""
"tb" => ""
"paged" => 0
"meta_key" => ""
"meta_value" => ""
"preview" => ""
"s" => ""
"sentence" => ""
"title" => ""
"fields" => ""
"menu_order" => ""
"embed" => ""
"category__in" => []
"category__not_in" => []
"category__and" => []
"post__in" => []
"post__not_in" => []
"post_name__in" => []
"tag__in" => []
"tag__not_in" => []
"tag__and" => []
"tag_slug__in" => []
"tag_slug__and" => []
"post_parent__in" => []
"post_parent__not_in" => []
"author__in" => []
"author__not_in" => []
"search_columns" => []
"meta_query" => []
"name" => ""
"ignore_sticky_posts" => false
"suppress_filters" => false
"cache_results" => true
"update_post_term_cache" => true
"update_menu_item_cache" => false
"lazy_load_term_meta" => true
"update_post_meta_cache" => true
"post_type" => ""
"posts_per_page" => 9
"nopaging" => false
"comments_per_page" => "50"
"no_found_rows" => false
"order" => "DESC"
]
+tax_query: null
+meta_query: WP_Meta_Query {#7000
+queries: []
+relation: null
+meta_table: null
+meta_id_column: null
+primary_table: null
+primary_id_column: null
#table_aliases: []
#clauses: []
#has_or_relation: false
}
+date_query: false
+queried_object: WP_Post {#6992
+ID: 5478
+post_author: "2"
+post_date: "2021-06-03 16:15:57"
+post_date_gmt: "2021-06-03 14:15:57"
+post_content: """
Press Release\r\n
\r\n
New York, NY, June 3, 2021\r\n
\r\n
\r\n
\r\n
<strong>Antidote Raises $23 Million to Scale Digital Patient Engagement Services</strong>\r\n
\r\n
<strong> </strong><strong>The funding, led by LBO France, will be used to enhance Antidote’s platform and accelerate new data products, connecting patients to research globally.</strong>\r\n
\r\n
\r\n
\r\n
<strong>New York, NY June 3, 2021</strong> — Antidote Technologies Limited (“Antidote”) today announced it has closed $23.2 million in funding to expand its digital patient engagement programs and clinical trial recruitment services. The funding round was led by LBO France, a private equity firm committed to supporting the growth of digital health, both in transforming health systems and accelerating medical R&D.\r\n
\r\n
Through its Digital Health 2 fund, LBO France is investing $10 million, joining existing major investors Merck Global Health Innovation Fund, Smedvig Capital, and Octopus Ventures, who between them are investing $13.2 million. Sebastien Woynar and Franck Noiret of LBO France will join the Antidote Board as a director and an observer, respectively.\r\n
\r\n
\r\n
\r\n
“The importance of clinical research has never been more clear than in the past year, as the industry stepped up to develop treatments and vaccines faster than could ever have been imagined,” said <strong>Laurent Schockmel, CEO of Antidote</strong>. “But despite the speed of response to Covid-19, some 80% of clinical trials are still delayed or closed due to a lack of participants. We welcome LBO France as a partner to help us achieve our mission of transforming the way that researchers and patients connect in an effort to accelerate medical research.”\r\n
\r\n
\r\n
\r\n
This new round of funding will allow the company to build on recent commercial success and accelerate growth. In 2020, Antidote increased its annual revenue by 66% and the number of projects handled by 158% over the previous year. In the first quarter of 2021 alone, the company surpassed its entire 2020 revenue.\r\n
\r\n
In concert with its extensive partner network of patient advocacy groups, Antidote operates with a truly patient-centric approach, balancing technology with a human touch. The funding will be used to enhance its clinical trial search engine, launch new products and services (including data insights), and expand its footprint internationally.\r\n
\r\n
\r\n
\r\n
“Antidote is a company in high-growth mode aiming to solve one of the most difficult problems of clinical research — connecting patients to trials,” said <strong>Sebastien Woynar</strong>, <strong>Investment Director at LBO France</strong>, “We’re excited to invest in an impressive team and a business that aligns so well with our investment objectives, to support their important mission.”\r\n
\r\n
\r\n
\r\n
<strong>Franck Noiret, Managing Director at LBO France</strong>, added “We believe that Antidote, as the fifth investment of our Digital Health 2 fund, will greatly benefit from our sectoral expertise and significant experience in the field of clinical trials.”\r\n
\r\n
\r\n
\r\n
Antidote understands that solving the problem of clinical trial patient recruitment will require innovative solutions to help willing and interested patients find, screen for, and enroll in medical research. With this new round of funding, the company will continue to lead the field in delivering such solutions. To learn more about Antidote’s work to accelerate medical research, please <a href="https://www.antidote.me/researchers/contact">get in touch</a>.
"""
+post_title: "LBO France’s Digital Health team leads a $23 million growth round in Antidote"
+post_excerpt: ""
+post_status: "publish"
+comment_status: "open"
+ping_status: "closed"
+post_password: ""
+post_name: "lbo-frances-digital-health-team-leads-a-23-million-growth-round-in-antidote"
+to_ping: ""
+pinged: ""
+post_modified: "2021-06-03 16:17:28"
+post_modified_gmt: "2021-06-03 14:17:28"
+post_content_filtered: ""
+post_parent: 0
+guid: "https://www.lbofrance.com/?p=5478"
+menu_order: 0
+post_type: "post"
+post_mime_type: ""
+comment_count: "0"
+filter: "raw"
+"status": "publish"
+"id": 5478
+"slug": "lbo-frances-digital-health-team-leads-a-23-million-growth-round-in-antidote"
+"custom": array:16 [
"_wpml_word_count" => "{"total":0,"to_translate":{"en":2,"fr":2,"it":2}}"
"_edit_lock" => "1622729707:2"
"_edit_last" => "2"
"_wpml_media_duplicate" => "1"
"_wpml_media_featured" => "1"
"_last_translation_edit_mode" => "native-editor"
"_yoast_wpseo_content_score" => "30"
"_yoast_wpseo_estimated-reading-time-minutes" => "3"
"banner" => ""
"_banner" => "field_5d0b8f67a8a14"
"linkedin" => ""
"_linkedin" => "field_5d0b8fa0a8a15"
"fichier" => "5479"
"_fichier" => "field_5d0b8faba8a16"
"_yoast_wpseo_primary_category" => "32"
"_wpml_media_has_media" => "1"
]
}
+queried_object_id: 5478
+request: """
\n
\t\t\tSELECT lbo_posts.*\n
\t\t\tFROM lbo_posts JOIN lbo_icl_translations wpml_translations\n
\t\t\t\t\t\t\tON lbo_posts.ID = wpml_translations.element_id\n
\t\t\t\t\t\t\t\tAND wpml_translations.element_type = CONCAT('post_', lbo_posts.post_type) \n
\t\t\tWHERE 1=1 AND lbo_posts.ID = 5478 AND lbo_posts.post_type = 'post' AND ( ( ( wpml_translations.language_code = 'en' OR 0 ) AND lbo_posts.post_type IN ('post','page','attachment','wp_block','wp_template','wp_template_part','wp_navigation','members','investments' ) ) OR lbo_posts.post_type NOT IN ('post','page','attachment','wp_block','wp_template','wp_template_part','wp_navigation','members','investments' ) )\n
\t\t\t\n
\t\t\tORDER BY lbo_posts.post_date DESC\n
\t\t\t\n
\t\t
"""
+posts: & array:1 [
0 => WP_Post {#6992}
]
+post_count: 1
+current_post: -1
+in_the_loop: false
+post: WP_Post {#6992}
+comment_count: 0
+current_comment: -1
+found_posts: 1
+max_num_pages: 0
+max_num_comment_pages: 0
+is_single: true
+is_preview: false
+is_page: false
+is_archive: false
+is_date: false
+is_year: false
+is_month: false
+is_day: false
+is_time: false
+is_author: false
+is_category: false
+is_tag: false
+is_tax: false
+is_search: false
+is_feed: false
+is_comment_feed: false
+is_trackback: false
+is_home: false
+is_privacy_policy: false
+is_404: false
+is_embed: false
+is_paged: false
+is_admin: false
+is_attachment: false
+is_singular: true
+is_robots: false
+is_favicon: false
+is_posts_page: false
+is_post_type_archive: false
-query_vars_hash: "2e765d6549273c90d0e031390044e21c"
-query_vars_changed: true
+thumbnails_cached: false
#allow_query_attachment_by_filename: false
-stopwords: null
-compat_fields: array:2 [
0 => "query_vars_hash"
1 => "query_vars_changed"
]
-compat_methods: array:2 [
0 => "init_query_flags"
1 => "parse_tax_query"
]
}
-_posts_class: "\Timber\Post"
}
#pagination: null
flag::STD_PROP_LIST: false
flag::ARRAY_AS_PROPS: false
iteratorClass: "Timber\PostsIterator"
storage: array:1 [
0 => Post {#7032
+ImageClass: "Timber\Image"
+PostClass: "Timber\Post"
+TermClass: "Timber\Term"
+object_type: "post"
+custom: array:16 [
"_wpml_word_count" => "{"total":0,"to_translate":{"en":2,"fr":2,"it":2}}"
"_edit_lock" => "1622729707:2"
"_edit_last" => "2"
"_wpml_media_duplicate" => "1"
"_wpml_media_featured" => "1"
"_last_translation_edit_mode" => "native-editor"
"_yoast_wpseo_content_score" => "30"
"_yoast_wpseo_estimated-reading-time-minutes" => "3"
"banner" => ""
"_banner" => "field_5d0b8f67a8a14"
"linkedin" => ""
"_linkedin" => "field_5d0b8fa0a8a15"
"fichier" => "5479"
"_fichier" => "field_5d0b8faba8a16"
"_yoast_wpseo_primary_category" => "32"
"_wpml_media_has_media" => "1"
]
#___content: null
#_permalink: null
#_next: []
#_prev: []
#_css_class: null
+id: 5478
+ID: 5478
+post_author: "2"
+post_content: """
Press Release\r\n
\r\n
New York, NY, June 3, 2021\r\n
\r\n
\r\n
\r\n
<strong>Antidote Raises $23 Million to Scale Digital Patient Engagement Services</strong>\r\n
\r\n
<strong> </strong><strong>The funding, led by LBO France, will be used to enhance Antidote’s platform and accelerate new data products, connecting patients to research globally.</strong>\r\n
\r\n
\r\n
\r\n
<strong>New York, NY June 3, 2021</strong> — Antidote Technologies Limited (“Antidote”) today announced it has closed $23.2 million in funding to expand its digital patient engagement programs and clinical trial recruitment services. The funding round was led by LBO France, a private equity firm committed to supporting the growth of digital health, both in transforming health systems and accelerating medical R&D.\r\n
\r\n
Through its Digital Health 2 fund, LBO France is investing $10 million, joining existing major investors Merck Global Health Innovation Fund, Smedvig Capital, and Octopus Ventures, who between them are investing $13.2 million. Sebastien Woynar and Franck Noiret of LBO France will join the Antidote Board as a director and an observer, respectively.\r\n
\r\n
\r\n
\r\n
“The importance of clinical research has never been more clear than in the past year, as the industry stepped up to develop treatments and vaccines faster than could ever have been imagined,” said <strong>Laurent Schockmel, CEO of Antidote</strong>. “But despite the speed of response to Covid-19, some 80% of clinical trials are still delayed or closed due to a lack of participants. We welcome LBO France as a partner to help us achieve our mission of transforming the way that researchers and patients connect in an effort to accelerate medical research.”\r\n
\r\n
\r\n
\r\n
This new round of funding will allow the company to build on recent commercial success and accelerate growth. In 2020, Antidote increased its annual revenue by 66% and the number of projects handled by 158% over the previous year. In the first quarter of 2021 alone, the company surpassed its entire 2020 revenue.\r\n
\r\n
In concert with its extensive partner network of patient advocacy groups, Antidote operates with a truly patient-centric approach, balancing technology with a human touch. The funding will be used to enhance its clinical trial search engine, launch new products and services (including data insights), and expand its footprint internationally.\r\n
\r\n
\r\n
\r\n
“Antidote is a company in high-growth mode aiming to solve one of the most difficult problems of clinical research — connecting patients to trials,” said <strong>Sebastien Woynar</strong>, <strong>Investment Director at LBO France</strong>, “We’re excited to invest in an impressive team and a business that aligns so well with our investment objectives, to support their important mission.”\r\n
\r\n
\r\n
\r\n
<strong>Franck Noiret, Managing Director at LBO France</strong>, added “We believe that Antidote, as the fifth investment of our Digital Health 2 fund, will greatly benefit from our sectoral expertise and significant experience in the field of clinical trials.”\r\n
\r\n
\r\n
\r\n
Antidote understands that solving the problem of clinical trial patient recruitment will require innovative solutions to help willing and interested patients find, screen for, and enroll in medical research. With this new round of funding, the company will continue to lead the field in delivering such solutions. To learn more about Antidote’s work to accelerate medical research, please <a href="https://www.antidote.me/researchers/contact">get in touch</a>.
"""
+post_date: "2021-06-03 16:15:57"
+post_excerpt: ""
+post_parent: 0
+post_status: "publish"
+post_title: "LBO France’s Digital Health team leads a $23 million growth round in Antidote"
+post_type: "post"
+slug: "lbo-frances-digital-health-team-leads-a-23-million-growth-round-in-antidote"
#__type: null
+"_wpml_word_count": "{"total":0,"to_translate":{"en":2,"fr":2,"it":2}}"
+"_edit_lock": "1622729707:2"
+"_edit_last": "2"
+"_wpml_media_duplicate": "1"
+"_wpml_media_featured": "1"
+"_last_translation_edit_mode": "native-editor"
+"_yoast_wpseo_content_score": "30"
+"_yoast_wpseo_estimated-reading-time-minutes": "3"
+"banner": ""
+"_banner": "field_5d0b8f67a8a14"
+"linkedin": ""
+"_linkedin": "field_5d0b8fa0a8a15"
+"fichier": "5479"
+"_fichier": "field_5d0b8faba8a16"
+"_yoast_wpseo_primary_category": "32"
+"_wpml_media_has_media": "1"
+"post_date_gmt": "2021-06-03 14:15:57"
+"comment_status": "open"
+"ping_status": "closed"
+"post_password": ""
+"post_name": "lbo-frances-digital-health-team-leads-a-23-million-growth-round-in-antidote"
+"to_ping": ""
+"pinged": ""
+"post_modified": "2021-06-03 16:17:28"
+"post_modified_gmt": "2021-06-03 14:17:28"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/?p=5478"
+"menu_order": 0
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"status": "publish"
}
]
}
"wp_head" => FunctionWrapper {#7033
-_class: null
-_function: "wp_head"
-_args: []
-_use_ob: false
}
"wp_footer" => FunctionWrapper {#7027
-_class: null
-_function: "wp_footer"
-_args: []
-_use_ob: false
}
]
Custom Context
array:24 [
"timber" => TimberManager {#4944
-configuration: array:3 [
"timber" => array:2 [
"views_location" => "/views"
"links" => array:2 [
"archives" => array:1 [
"news" => "post"
]
"pages" => array:1 [
"page_exemple" => 2
]
]
]
"wordpress" => array:7 [
"show_admin_bar" => false
"clear_head_for_yoast" => true
"query_vars" => array:5 [
0 => "custom_var_1"
1 => "custom_var_2"
2 => "custom_var_3"
3 => "custom_var_4"
4 => "custom_var_5"
]
"theme_supports" => array:5 [
0 => "title-tag"
1 => "post-formats"
2 => "post-thumbnails"
3 => "menus"
4 => array:2 [
"support" => "html5"
"arg" => array:5 [
0 => "comment-list"
1 => "comment-form"
2 => "search-form"
3 => "gallery"
4 => "caption"
]
]
]
"menus" => array:3 [
"primary" => "Menu Principal"
"secondary" => "Menu Secondaire"
"footer" => "Menu Footer"
]
"remove_action" => array:1 [
"wp_head" => "wp_generator"
]
"images_sizes" => array:1 [
"square_sm" => array:3 [
"w" => 300
"h" => 300
"crop" => array:2 [
0 => "center"
1 => "center"
]
]
]
]
"acf" => array:2 [
"google_map_api_key" => "AIzaSyDGF98psyVSiyiVhFovqfhMDrGJ-Ls2Uoc"
"options" => array:1 [
"options_page" => array:2 [
"page" => array:4 [
"page_title" => "Option"
"menu_title" => "Options"
"menu_slug" => "options"
"capability" => "edit_posts"
]
"sub_menus" => array:4 [
0 => array:2 [ …2]
1 => array:2 [ …2]
2 => array:2 [ …2]
3 => array:2 [ …2]
]
]
]
]
]
}
"services" => TimberService {#7069}
"translations" => array:36 [
"welcome" => "Yagami Starter Theme"
"filter_by_status" => "Screening by category"
"sector" => "Sector"
"type_of_operation" => "Status"
"filter_by_team" => "Screening by team"
"filter_by_location" => "Screening by location"
"invest_relation" => "Investor Relations"
"esg" => "ESG"
"compliance" => "Compliance"
"board" => "Board of Directors"
"executive_committee" => "Executive Committee"
"invest" => "Investment"
"admin_finance" => "Administration & Finance"
"back_to_news" => "back to news"
"back_to_team" => "Back to team"
"filter" => "Screening"
"discover" => "Discover"
"lbo_mid" => "LBO Mid Cap"
"lbo_small" => "LBO Small Cap"
"venture" => "Venture"
"real_estate" => "Real Estate"
"debt" => "Debt"
"send" => "Send"
"detention" => "Holding period"
"date_acquisition" => "Date d'acquisition"
"date_cession" => "Date de cession"
"country" => "pays"
"site" => "website"
"society" => "Company"
"press" => "Communiqué de presse"
"download" => "Télécharger le communiqué de presse"
"all_members" => "See entire team "
"all_news" => "All"
"show_more" => "Show more"
"all" => "All"
"cookiepro_params" => "Paramètres des cookies"
]
"img" => "https://www.lbofrance.com/wp-content/themes/yagami/web/src/img"
"dist" => "https://www.lbofrance.com/wp-content/themes/yagami/web/dist"
"options" => array:8 [
"footer_adveris_link" => "https://www.adveris.fr/"
"footer_adveris_title" => "Website creation : Adveris"
"footer_links" => array:2 [
0 => array:1 [
"link" => array:3 [
"title" => "Videos : Raccord Image"
"url" => "http://www.raccordimage.com/"
"target" => "_blank"
]
]
1 => array:1 [
"link" => array:3 [
"title" => "Photos : Encre Noire"
"url" => "http://www.encrenoire.com/en"
"target" => "_blank"
]
]
]
"footer_ml" => array:3 [
0 => array:2 [
"title" => "Copyright © 2020 LBO FRANCE"
"link" => ""
]
1 => array:2 [
"title" => "Legal notice"
"link" => "/en/disclaimer/"
]
2 => array:2 [
"title" => "Contact"
"link" => "https://www.lbofrance.com/en/contact/"
]
]
"link_externe" => array:3 [
"title" => "Un Autre Regard Créatif"
"url" => "https://www.un-autre-regard-creatif.com/"
"target" => "_blank"
]
"script_header" => """
<!-- CookiePro Cookies Consent Notice start for www.lbofrance.com -->\r\n
<script type="text/javascript" src="https://cookie-cdn.cookiepro.com/consent/0c5631b1-59d9-4b6d-91b8-d1cbc19ebae7/OtAutoBlock.js" ></script>\r\n
<script src="https://cookie-cdn.cookiepro.com/scripttemplates/otSDKStub.js" data-document-language="true" type="text/javascript" charset="UTF-8" data-domain-script="0c5631b1-59d9-4b6d-91b8-d1cbc19ebae7" ></script>\r\n
<script type="text/javascript">\r\n
function OptanonWrapper() { }\r\n
</script>\r\n
<!-- CookiePro Cookies Consent Notice end for www.lbofrance.com -->
"""
"social_linkedin" => "https://www.linkedin.com/company/lbo-france?originalSubdomain=it"
"team_link" => "https://www.lbofrance.com/en/team/"
]
"is_device" => false
"links" => array:2 [
"archives" => array:1 [
"news" => "https://www.lbofrance.com/en/news-and-press-release/"
]
"pages" => array:1 [
"page_exemple" => "https://www.lbofrance.com/en/lbo-frances-digital-health-team-leads-a-23-million-growth-round-in-antidote/"
]
]
"clear_head_for_yoast" => true
"google_map_api_key" => "AIzaSyDGF98psyVSiyiVhFovqfhMDrGJ-Ls2Uoc"
"server" => array:46 [
"SERVER_SOFTWARE" => "Apache/2.4.56 (Debian)"
"REQUEST_URI" => "/en/lbo-frances-digital-health-team-leads-a-23-million-growth-round-in-antidote/"
"DOCUMENT_ROOT" => "/var/www/lbofrance.com/docs"
"TMPDIR" => "/tmp"
"TMP" => "/tmp"
"TEMP" => "/tmp"
"PATH" => "/usr/local/sbin:/usr/local/bin:/usr/sbin:/usr/bin:/sbin:/bin"
"HOSTNAME" => "a1c033e8c2ed"
"USER" => "phpuser"
"HOME" => "/var/www"
"SCRIPT_NAME" => "/index.php"
"QUERY_STRING" => ""
"REQUEST_METHOD" => "GET"
"SERVER_PROTOCOL" => "HTTP/1.1"
"GATEWAY_INTERFACE" => "CGI/1.1"
"REDIRECT_URL" => "/en/lbo-frances-digital-health-team-leads-a-23-million-growth-round-in-antidote/"
"REMOTE_PORT" => "32942"
"SCRIPT_FILENAME" => "/var/www/lbofrance.com/docs/index.php"
"SERVER_ADMIN" => "[no address given]"
"CONTEXT_DOCUMENT_ROOT" => "/var/www/lbofrance.com/docs"
"CONTEXT_PREFIX" => ""
"REQUEST_SCHEME" => "https"
"REMOTE_ADDR" => "3.233.219.103"
"SERVER_PORT" => "443"
"SERVER_ADDR" => "192.168.219.15"
"SERVER_NAME" => "www.lbofrance.com"
"SERVER_SIGNATURE" => "<address>Apache/2.4.56 (Debian) Server at www.lbofrance.com Port 443</address>\n"
"HTTP_CONNECTION" => "Keep-Alive"
"HTTP_HOST" => "www.lbofrance.com"
"HTTP_ACCEPT_ENCODING" => "br,gzip"
"HTTP_IF_MODIFIED_SINCE" => "Thu, 11 Aug 2022 14:21:48 GMT"
"HTTP_ACCEPT_LANGUAGE" => "en-US,en;q=0.5"
"HTTP_ACCEPT" => "text/html,application/xhtml+xml,application/xml;q=0.9,*/*;q=0.8"
"HTTP_USER_AGENT" => "CCBot/2.0 (https://commoncrawl.org/faq/)"
"proxy-nokeepalive" => "1"
"SSL_TLS_SNI" => "www.lbofrance.com"
"HTTPS" => "on"
"HTTP_AUTHORIZATION" => ""
"REDIRECT_STATUS" => "200"
"REDIRECT_SSL_TLS_SNI" => "www.lbofrance.com"
"REDIRECT_HTTPS" => "on"
"REDIRECT_HTTP_AUTHORIZATION" => ""
"FCGI_ROLE" => "RESPONDER"
"PHP_SELF" => "/index.php"
"REQUEST_TIME_FLOAT" => 1686115052.2283
"REQUEST_TIME" => 1686115052
]
"lang" => "en"
"current_language" => "en"
"http_host" => "https://www.lbofrance.com"
"wp_title" => "LBO France’s Digital Health team leads a $23 million growth round in Antidote - LBO France"
"body_class" => "post-template-default single single-post postid-5478 single-format-standard"
"site" => Site {#7064
+admin_email: "admin@adveris.fr"
+blogname: null
+charset: "UTF-8"
+description: ""
+id: null
+language: "en_US"
+multisite: false
+name: "LBO France"
+pingback_url: "https://www.lbofrance.com/xmlrpc.php"
+siteurl: null
+theme: Theme {#7037
+name: "Yagami"
+version: ""
+parent: false
+parent_slug: null
+slug: "yagami"
+uri: "https://www.lbofrance.com/wp-content/themes/yagami"
-theme: WP_Theme {#7039
+update: false
-theme_root: "/var/www/lbofrance.com/docs/wp-content/themes"
-headers: array:14 [
"Name" => "Yagami"
"ThemeURI" => ""
"Description" => "Custom starter to build wordpress theme from scratch"
"Author" => "Kévin Vacherot"
"AuthorURI" => "https://www.linkedin.com/in/k%C3%A9vin-vacherot-b9a004a2/"
"Version" => ""
"Template" => ""
"Status" => ""
"Tags" => "yagami, blank"
"TextDomain" => "Yagami"
"DomainPath" => ""
"RequiresWP" => ""
"RequiresPHP" => ""
"UpdateURI" => ""
]
-headers_sanitized: array:2 [
"Name" => "Yagami"
"Version" => ""
]
-block_theme: false
-name_translated: null
-errors: null
-stylesheet: "yagami"
-template: "yagami"
-parent: null
-theme_root_uri: "https://www.lbofrance.com/wp-content/themes"
-textdomain_loaded: null
-cache_hash: "37a7699c69410d0bf18f875580b71453"
}
+id: null
+ID: null
+object_type: null
}
+title: "LBO France"
+url: "https://www.lbofrance.com/en/"
+home_url: "https://www.lbofrance.com/en/"
+site_url: "https://www.lbofrance.com"
+rdf: "https://www.lbofrance.com/en/feed/rdf/"
+rss: "https://www.lbofrance.com/en/feed/rss/"
+rss2: "https://www.lbofrance.com/en/feed/"
+atom: "https://www.lbofrance.com/en/feed/atom/"
+ID: null
+object_type: null
+"pingback": "https://www.lbofrance.com/xmlrpc.php"
}
"request" => Request {#7038
+post: []
+get: []
+id: null
+ID: null
+object_type: null
}
"user" => false
"theme" => Theme {#7037}
"posts" => PostQuery {#7035
+found_posts: 1
#userQuery: false
#queryIterator: QueryIterator {#7034
-_query: WP_Query {#4911
+query: array:2 [
"page" => ""
"name" => "lbo-frances-digital-health-team-leads-a-23-million-growth-round-in-antidote"
]
+query_vars: array:67 [
"page" => 0
"error" => ""
"m" => ""
"p" => 5478
"post_parent" => ""
"subpost" => ""
"subpost_id" => ""
"attachment" => ""
"attachment_id" => 0
"pagename" => ""
"page_id" => ""
"second" => ""
"minute" => ""
"hour" => ""
"day" => 0
"monthnum" => 0
"year" => 0
"w" => 0
"category_name" => ""
"tag" => ""
"cat" => ""
"tag_id" => ""
"author" => ""
"author_name" => ""
"feed" => ""
"tb" => ""
"paged" => 0
"meta_key" => ""
"meta_value" => ""
"preview" => ""
"s" => ""
"sentence" => ""
"title" => ""
"fields" => ""
"menu_order" => ""
"embed" => ""
"category__in" => []
"category__not_in" => []
"category__and" => []
"post__in" => []
"post__not_in" => []
"post_name__in" => []
"tag__in" => []
"tag__not_in" => []
"tag__and" => []
"tag_slug__in" => []
"tag_slug__and" => []
"post_parent__in" => []
"post_parent__not_in" => []
"author__in" => []
"author__not_in" => []
"search_columns" => []
"meta_query" => []
"name" => ""
"ignore_sticky_posts" => false
"suppress_filters" => false
"cache_results" => true
"update_post_term_cache" => true
"update_menu_item_cache" => false
"lazy_load_term_meta" => true
"update_post_meta_cache" => true
"post_type" => ""
"posts_per_page" => 9
"nopaging" => false
"comments_per_page" => "50"
"no_found_rows" => false
"order" => "DESC"
]
+tax_query: null
+meta_query: WP_Meta_Query {#7000
+queries: []
+relation: null
+meta_table: null
+meta_id_column: null
+primary_table: null
+primary_id_column: null
#table_aliases: []
#clauses: []
#has_or_relation: false
}
+date_query: false
+queried_object: WP_Post {#6992
+ID: 5478
+post_author: "2"
+post_date: "2021-06-03 16:15:57"
+post_date_gmt: "2021-06-03 14:15:57"
+post_content: """
Press Release\r\n
\r\n
New York, NY, June 3, 2021\r\n
\r\n
\r\n
\r\n
<strong>Antidote Raises $23 Million to Scale Digital Patient Engagement Services</strong>\r\n
\r\n
<strong> </strong><strong>The funding, led by LBO France, will be used to enhance Antidote’s platform and accelerate new data products, connecting patients to research globally.</strong>\r\n
\r\n
\r\n
\r\n
<strong>New York, NY June 3, 2021</strong> — Antidote Technologies Limited (“Antidote”) today announced it has closed $23.2 million in funding to expand its digital patient engagement programs and clinical trial recruitment services. The funding round was led by LBO France, a private equity firm committed to supporting the growth of digital health, both in transforming health systems and accelerating medical R&D.\r\n
\r\n
Through its Digital Health 2 fund, LBO France is investing $10 million, joining existing major investors Merck Global Health Innovation Fund, Smedvig Capital, and Octopus Ventures, who between them are investing $13.2 million. Sebastien Woynar and Franck Noiret of LBO France will join the Antidote Board as a director and an observer, respectively.\r\n
\r\n
\r\n
\r\n
“The importance of clinical research has never been more clear than in the past year, as the industry stepped up to develop treatments and vaccines faster than could ever have been imagined,” said <strong>Laurent Schockmel, CEO of Antidote</strong>. “But despite the speed of response to Covid-19, some 80% of clinical trials are still delayed or closed due to a lack of participants. We welcome LBO France as a partner to help us achieve our mission of transforming the way that researchers and patients connect in an effort to accelerate medical research.”\r\n
\r\n
\r\n
\r\n
This new round of funding will allow the company to build on recent commercial success and accelerate growth. In 2020, Antidote increased its annual revenue by 66% and the number of projects handled by 158% over the previous year. In the first quarter of 2021 alone, the company surpassed its entire 2020 revenue.\r\n
\r\n
In concert with its extensive partner network of patient advocacy groups, Antidote operates with a truly patient-centric approach, balancing technology with a human touch. The funding will be used to enhance its clinical trial search engine, launch new products and services (including data insights), and expand its footprint internationally.\r\n
\r\n
\r\n
\r\n
“Antidote is a company in high-growth mode aiming to solve one of the most difficult problems of clinical research — connecting patients to trials,” said <strong>Sebastien Woynar</strong>, <strong>Investment Director at LBO France</strong>, “We’re excited to invest in an impressive team and a business that aligns so well with our investment objectives, to support their important mission.”\r\n
\r\n
\r\n
\r\n
<strong>Franck Noiret, Managing Director at LBO France</strong>, added “We believe that Antidote, as the fifth investment of our Digital Health 2 fund, will greatly benefit from our sectoral expertise and significant experience in the field of clinical trials.”\r\n
\r\n
\r\n
\r\n
Antidote understands that solving the problem of clinical trial patient recruitment will require innovative solutions to help willing and interested patients find, screen for, and enroll in medical research. With this new round of funding, the company will continue to lead the field in delivering such solutions. To learn more about Antidote’s work to accelerate medical research, please <a href="https://www.antidote.me/researchers/contact">get in touch</a>.
"""
+post_title: "LBO France’s Digital Health team leads a $23 million growth round in Antidote"
+post_excerpt: ""
+post_status: "publish"
+comment_status: "open"
+ping_status: "closed"
+post_password: ""
+post_name: "lbo-frances-digital-health-team-leads-a-23-million-growth-round-in-antidote"
+to_ping: ""
+pinged: ""
+post_modified: "2021-06-03 16:17:28"
+post_modified_gmt: "2021-06-03 14:17:28"
+post_content_filtered: ""
+post_parent: 0
+guid: "https://www.lbofrance.com/?p=5478"
+menu_order: 0
+post_type: "post"
+post_mime_type: ""
+comment_count: "0"
+filter: "raw"
+"status": "publish"
+"id": 5478
+"slug": "lbo-frances-digital-health-team-leads-a-23-million-growth-round-in-antidote"
+"custom": array:16 [
"_wpml_word_count" => "{"total":0,"to_translate":{"en":2,"fr":2,"it":2}}"
"_edit_lock" => "1622729707:2"
"_edit_last" => "2"
"_wpml_media_duplicate" => "1"
"_wpml_media_featured" => "1"
"_last_translation_edit_mode" => "native-editor"
"_yoast_wpseo_content_score" => "30"
"_yoast_wpseo_estimated-reading-time-minutes" => "3"
"banner" => ""
"_banner" => "field_5d0b8f67a8a14"
"linkedin" => ""
"_linkedin" => "field_5d0b8fa0a8a15"
"fichier" => "5479"
"_fichier" => "field_5d0b8faba8a16"
"_yoast_wpseo_primary_category" => "32"
"_wpml_media_has_media" => "1"
]
}
+queried_object_id: 5478
+request: """
\n
\t\t\tSELECT lbo_posts.*\n
\t\t\tFROM lbo_posts JOIN lbo_icl_translations wpml_translations\n
\t\t\t\t\t\t\tON lbo_posts.ID = wpml_translations.element_id\n
\t\t\t\t\t\t\t\tAND wpml_translations.element_type = CONCAT('post_', lbo_posts.post_type) \n
\t\t\tWHERE 1=1 AND lbo_posts.ID = 5478 AND lbo_posts.post_type = 'post' AND ( ( ( wpml_translations.language_code = 'en' OR 0 ) AND lbo_posts.post_type IN ('post','page','attachment','wp_block','wp_template','wp_template_part','wp_navigation','members','investments' ) ) OR lbo_posts.post_type NOT IN ('post','page','attachment','wp_block','wp_template','wp_template_part','wp_navigation','members','investments' ) )\n
\t\t\t\n
\t\t\tORDER BY lbo_posts.post_date DESC\n
\t\t\t\n
\t\t
"""
+posts: & array:1 [
0 => WP_Post {#6992}
]
+post_count: 1
+current_post: -1
+in_the_loop: false
+post: WP_Post {#6992}
+comment_count: 0
+current_comment: -1
+found_posts: 1
+max_num_pages: 0
+max_num_comment_pages: 0
+is_single: true
+is_preview: false
+is_page: false
+is_archive: false
+is_date: false
+is_year: false
+is_month: false
+is_day: false
+is_time: false
+is_author: false
+is_category: false
+is_tag: false
+is_tax: false
+is_search: false
+is_feed: false
+is_comment_feed: false
+is_trackback: false
+is_home: false
+is_privacy_policy: false
+is_404: false
+is_embed: false
+is_paged: false
+is_admin: false
+is_attachment: false
+is_singular: true
+is_robots: false
+is_favicon: false
+is_posts_page: false
+is_post_type_archive: false
-query_vars_hash: "2e765d6549273c90d0e031390044e21c"
-query_vars_changed: true
+thumbnails_cached: false
#allow_query_attachment_by_filename: false
-stopwords: null
-compat_fields: array:2 [
0 => "query_vars_hash"
1 => "query_vars_changed"
]
-compat_methods: array:2 [
0 => "init_query_flags"
1 => "parse_tax_query"
]
}
-_posts_class: "\Timber\Post"
}
#pagination: null
flag::STD_PROP_LIST: false
flag::ARRAY_AS_PROPS: false
iteratorClass: "Timber\PostsIterator"
storage: array:1 [
0 => Post {#7032
+ImageClass: "Timber\Image"
+PostClass: "Timber\Post"
+TermClass: "Timber\Term"
+object_type: "post"
+custom: array:16 [
"_wpml_word_count" => "{"total":0,"to_translate":{"en":2,"fr":2,"it":2}}"
"_edit_lock" => "1622729707:2"
"_edit_last" => "2"
"_wpml_media_duplicate" => "1"
"_wpml_media_featured" => "1"
"_last_translation_edit_mode" => "native-editor"
"_yoast_wpseo_content_score" => "30"
"_yoast_wpseo_estimated-reading-time-minutes" => "3"
"banner" => ""
"_banner" => "field_5d0b8f67a8a14"
"linkedin" => ""
"_linkedin" => "field_5d0b8fa0a8a15"
"fichier" => "5479"
"_fichier" => "field_5d0b8faba8a16"
"_yoast_wpseo_primary_category" => "32"
"_wpml_media_has_media" => "1"
]
#___content: null
#_permalink: null
#_next: []
#_prev: []
#_css_class: null
+id: 5478
+ID: 5478
+post_author: "2"
+post_content: """
Press Release\r\n
\r\n
New York, NY, June 3, 2021\r\n
\r\n
\r\n
\r\n
<strong>Antidote Raises $23 Million to Scale Digital Patient Engagement Services</strong>\r\n
\r\n
<strong> </strong><strong>The funding, led by LBO France, will be used to enhance Antidote’s platform and accelerate new data products, connecting patients to research globally.</strong>\r\n
\r\n
\r\n
\r\n
<strong>New York, NY June 3, 2021</strong> — Antidote Technologies Limited (“Antidote”) today announced it has closed $23.2 million in funding to expand its digital patient engagement programs and clinical trial recruitment services. The funding round was led by LBO France, a private equity firm committed to supporting the growth of digital health, both in transforming health systems and accelerating medical R&D.\r\n
\r\n
Through its Digital Health 2 fund, LBO France is investing $10 million, joining existing major investors Merck Global Health Innovation Fund, Smedvig Capital, and Octopus Ventures, who between them are investing $13.2 million. Sebastien Woynar and Franck Noiret of LBO France will join the Antidote Board as a director and an observer, respectively.\r\n
\r\n
\r\n
\r\n
“The importance of clinical research has never been more clear than in the past year, as the industry stepped up to develop treatments and vaccines faster than could ever have been imagined,” said <strong>Laurent Schockmel, CEO of Antidote</strong>. “But despite the speed of response to Covid-19, some 80% of clinical trials are still delayed or closed due to a lack of participants. We welcome LBO France as a partner to help us achieve our mission of transforming the way that researchers and patients connect in an effort to accelerate medical research.”\r\n
\r\n
\r\n
\r\n
This new round of funding will allow the company to build on recent commercial success and accelerate growth. In 2020, Antidote increased its annual revenue by 66% and the number of projects handled by 158% over the previous year. In the first quarter of 2021 alone, the company surpassed its entire 2020 revenue.\r\n
\r\n
In concert with its extensive partner network of patient advocacy groups, Antidote operates with a truly patient-centric approach, balancing technology with a human touch. The funding will be used to enhance its clinical trial search engine, launch new products and services (including data insights), and expand its footprint internationally.\r\n
\r\n
\r\n
\r\n
“Antidote is a company in high-growth mode aiming to solve one of the most difficult problems of clinical research — connecting patients to trials,” said <strong>Sebastien Woynar</strong>, <strong>Investment Director at LBO France</strong>, “We’re excited to invest in an impressive team and a business that aligns so well with our investment objectives, to support their important mission.”\r\n
\r\n
\r\n
\r\n
<strong>Franck Noiret, Managing Director at LBO France</strong>, added “We believe that Antidote, as the fifth investment of our Digital Health 2 fund, will greatly benefit from our sectoral expertise and significant experience in the field of clinical trials.”\r\n
\r\n
\r\n
\r\n
Antidote understands that solving the problem of clinical trial patient recruitment will require innovative solutions to help willing and interested patients find, screen for, and enroll in medical research. With this new round of funding, the company will continue to lead the field in delivering such solutions. To learn more about Antidote’s work to accelerate medical research, please <a href="https://www.antidote.me/researchers/contact">get in touch</a>.
"""
+post_date: "2021-06-03 16:15:57"
+post_excerpt: ""
+post_parent: 0
+post_status: "publish"
+post_title: "LBO France’s Digital Health team leads a $23 million growth round in Antidote"
+post_type: "post"
+slug: "lbo-frances-digital-health-team-leads-a-23-million-growth-round-in-antidote"
#__type: null
+"_wpml_word_count": "{"total":0,"to_translate":{"en":2,"fr":2,"it":2}}"
+"_edit_lock": "1622729707:2"
+"_edit_last": "2"
+"_wpml_media_duplicate": "1"
+"_wpml_media_featured": "1"
+"_last_translation_edit_mode": "native-editor"
+"_yoast_wpseo_content_score": "30"
+"_yoast_wpseo_estimated-reading-time-minutes": "3"
+"banner": ""
+"_banner": "field_5d0b8f67a8a14"
+"linkedin": ""
+"_linkedin": "field_5d0b8fa0a8a15"
+"fichier": "5479"
+"_fichier": "field_5d0b8faba8a16"
+"_yoast_wpseo_primary_category": "32"
+"_wpml_media_has_media": "1"
+"post_date_gmt": "2021-06-03 14:15:57"
+"comment_status": "open"
+"ping_status": "closed"
+"post_password": ""
+"post_name": "lbo-frances-digital-health-team-leads-a-23-million-growth-round-in-antidote"
+"to_ping": ""
+"pinged": ""
+"post_modified": "2021-06-03 16:17:28"
+"post_modified_gmt": "2021-06-03 14:17:28"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/?p=5478"
+"menu_order": 0
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"status": "publish"
}
]
}
"wp_head" => FunctionWrapper {#7033
-_class: null
-_function: "wp_head"
-_args: []
-_use_ob: false
}
"wp_footer" => FunctionWrapper {#7027
-_class: null
-_function: "wp_footer"
-_args: []
-_use_ob: false
}
"menu" => array:3 [
"primary" => Menu {#7025
+MenuItemClass: "Timber\MenuItem"
+PostClass: "Timber\Post"
+depth: 0
+items: array:4 [
0 => MenuItem {#2368
+children: array:5 [
0 => MenuItem {#7748
+children: []
+has_child_class: false
+classes: array:5 [ …5]
+class: "menu-item menu-item-type-custom menu-item-object-custom menu-item-5083"
+level: 1
+post_name: "presentation"
+url: "https://www.lbofrance.com/en/about-lbo-france#section-0"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7025}
#_name: null
#_menu_item_object_id: "5083"
#_menu_item_url: "https://www.lbofrance.com/en/about-lbo-france#section-0"
#menu_object: Post {#7743 …62}
+id: 5083
+ID: 5083
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:9 [ …9]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": ""
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": "Presentation"
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "2485"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_wp_old_date": array:4 [ …4]
+"post_date_gmt": "2021-03-23 11:33:44"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/?p=5083"
+"menu_order": 2
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 5083
+"menu_item_parent": "2485"
+"object_id": "5083"
+"object": "custom"
+"type_label": "Custom Link"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "Presentation"
+"status": "publish"
+"name": "Presentation"
}
1 => MenuItem {#7740
+children: []
+has_child_class: false
+classes: array:5 [ …5]
+class: "menu-item menu-item-type-custom menu-item-object-custom menu-item-5085"
+level: 1
+post_name: "board-of-directors"
+url: "https://www.lbofrance.com/en/about-lbo-france#section-1"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7025}
#_name: null
#_menu_item_object_id: "5085"
#_menu_item_url: "https://www.lbofrance.com/en/about-lbo-france#section-1"
#menu_object: Post {#7753 …62}
+id: 5085
+ID: 5085
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:9 [ …9]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": ""
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": "Board of Directors"
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "2485"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_wp_old_date": array:4 [ …4]
+"post_date_gmt": "2021-03-23 11:33:44"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/?p=5085"
+"menu_order": 3
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 5085
+"menu_item_parent": "2485"
+"object_id": "5085"
+"object": "custom"
+"type_label": "Custom Link"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "Board of Directors"
+"status": "publish"
+"name": "Board of Directors"
}
2 => MenuItem {#7746
+children: []
+has_child_class: false
+classes: array:5 [ …5]
+class: "menu-item menu-item-type-custom menu-item-object-custom menu-item-5087"
+level: 1
+post_name: "operational-value-creation"
+url: "https://www.lbofrance.com/en/about-lbo-france#section-2"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7025}
#_name: null
#_menu_item_object_id: "5087"
#_menu_item_url: "https://www.lbofrance.com/en/about-lbo-france#section-2"
#menu_object: Post {#7744 …62}
+id: 5087
+ID: 5087
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:9 [ …9]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": ""
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": "Operational Value Creation"
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "2485"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_wp_old_date": array:4 [ …4]
+"post_date_gmt": "2021-03-23 11:33:44"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/?p=5087"
+"menu_order": 4
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 5087
+"menu_item_parent": "2485"
+"object_id": "5087"
+"object": "custom"
+"type_label": "Custom Link"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "Operational Value Creation"
+"status": "publish"
+"name": "Operational Value Creation"
}
3 => MenuItem {#7735
+children: []
+has_child_class: false
+classes: array:5 [ …5]
+class: "menu-item menu-item-type-custom menu-item-object-custom menu-item-5088"
+level: 1
+post_name: "esg"
+url: "https://www.lbofrance.com/en/about-lbo-france#section-3"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7025}
#_name: null
#_menu_item_object_id: "5088"
#_menu_item_url: "https://www.lbofrance.com/en/about-lbo-france#section-3"
#menu_object: Post {#7742 …62}
+id: 5088
+ID: 5088
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:9 [ …9]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": ""
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": "ESG"
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "2485"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_wp_old_date": array:4 [ …4]
+"post_date_gmt": "2021-03-23 11:33:44"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/?p=5088"
+"menu_order": 5
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 5088
+"menu_item_parent": "2485"
+"object_id": "5088"
+"object": "custom"
+"type_label": "Custom Link"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "ESG"
+"status": "publish"
+"name": "ESG"
}
4 => MenuItem {#7737
+children: []
+has_child_class: false
+classes: array:5 [ …5]
+class: "menu-item menu-item-type-custom menu-item-object-custom menu-item-5090"
+level: 1
+post_name: "investor-relations"
+url: "https://www.lbofrance.com/en/about-lbo-france#section-4"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7025}
#_name: null
#_menu_item_object_id: "5090"
#_menu_item_url: "https://www.lbofrance.com/en/about-lbo-france#section-4"
#menu_object: Post {#7738 …62}
+id: 5090
+ID: 5090
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:9 [ …9]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": ""
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": "Investor Relations"
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "2485"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_wp_old_date": array:4 [ …4]
+"post_date_gmt": "2021-03-23 11:33:44"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/?p=5090"
+"menu_order": 6
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 5090
+"menu_item_parent": "2485"
+"object_id": "5090"
+"object": "custom"
+"type_label": "Custom Link"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "Investor Relations"
+"status": "publish"
+"name": "Investor Relations"
}
]
+has_child_class: true
+classes: array:6 [
0 => ""
1 => "menu-item"
2 => "menu-item-type-post_type"
3 => "menu-item-object-page"
4 => "menu-item-2485"
5 => "menu-item-has-children"
]
+class: "menu-item menu-item-type-post_type menu-item-object-page menu-item-2485 menu-item-has-children"
+level: 0
+post_name: "2485"
+url: "https://www.lbofrance.com/en/about-lbo-france/"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7025}
#_name: null
#_menu_item_object_id: "1555"
#_menu_item_url: ""
#menu_object: Post {#983
+ImageClass: "Timber\Image"
+PostClass: "Timber\Post"
+TermClass: "Timber\Term"
+object_type: "post"
+custom: array:10 [
"_menu_item_type" => "post_type"
"_menu_item_menu_item_parent" => "0"
"_menu_item_object_id" => "1555"
"_menu_item_object" => "page"
"_menu_item_target" => ""
"_menu_item_classes" => array:1 [ …1]
"_menu_item_xfn" => ""
"_menu_item_url" => ""
"_last_translation_edit_mode" => "translation-editor"
"_wp_old_date" => array:4 [ …4]
]
#___content: null
#_permalink: null
#_next: []
#_prev: []
#_css_class: null
+id: 2485
+ID: 2485
+post_author: "1"
+post_content: " "
+post_date: "2023-03-21 18:25:18"
+post_excerpt: ""
+post_parent: 0
+post_status: "publish"
+post_title: ""
+post_type: "nav_menu_item"
+slug: "2485"
#__type: null
+"_menu_item_type": "post_type"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object_id": "1555"
+"_menu_item_object": "page"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [
0 => ""
]
+"_menu_item_xfn": ""
+"_menu_item_url": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:4 [
0 => "2019-12-27"
1 => "2021-05-21"
2 => "2022-09-09"
3 => "2022-09-12"
]
+"post_date_gmt": "2019-12-27 10:52:08"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"post_name": "2485"
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/2485/"
+"menu_order": 1
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2485
+"menu_item_parent": "0"
+"object_id": "1555"
+"object": "page"
+"type_label": "Page"
+"url": "https://www.lbofrance.com/en/about-lbo-france/"
+"target": ""
+"attr_title": ""
+"description": ""
+"classes": array:4 [
0 => ""
1 => "menu-item"
2 => "menu-item-type-post_type"
3 => "menu-item-object-page"
]
+"xfn": ""
+"current": false
+"current_item_ancestor": false
+"current_item_parent": false
+"__title": "Company"
+"status": "publish"
}
+id: 2485
+ID: 2485
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:10 [
"_menu_item_type" => "post_type"
"_menu_item_menu_item_parent" => "0"
"_menu_item_object_id" => "1555"
"_menu_item_object" => "page"
"_menu_item_target" => ""
"_menu_item_classes" => array:1 [
0 => ""
]
"_menu_item_xfn" => ""
"_menu_item_url" => ""
"_last_translation_edit_mode" => "translation-editor"
"_wp_old_date" => array:4 [
0 => "2019-12-27"
1 => "2021-05-21"
2 => "2022-09-09"
3 => "2022-09-12"
]
]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": " "
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": ""
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "post_type"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object": "page"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [
0 => ""
]
+"_menu_item_xfn": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:4 [
0 => "2019-12-27"
1 => "2021-05-21"
2 => "2022-09-09"
3 => "2022-09-12"
]
+"post_date_gmt": "2019-12-27 10:52:08"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/2485/"
+"menu_order": 1
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2485
+"menu_item_parent": "0"
+"object_id": "1555"
+"object": "page"
+"type_label": "Page"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "Company"
+"status": "publish"
+"name": "Company"
}
1 => MenuItem {#7733
+children: array:5 [
0 => MenuItem {#7731
+children: []
+has_child_class: false
+classes: array:5 [ …5]
+class: "menu-item menu-item-type-post_type menu-item-object-page menu-item-2487"
+level: 1
+post_name: "2487"
+url: "https://www.lbofrance.com/en/lbo-mid-cap/"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7025}
#_name: null
#_menu_item_object_id: "1536"
#_menu_item_url: ""
#menu_object: Post {#7734 …63}
+id: 2487
+ID: 2487
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:10 [ …10]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": " "
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": ""
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "post_type"
+"_menu_item_menu_item_parent": "2486"
+"_menu_item_object": "page"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:4 [ …4]
+"post_date_gmt": "2019-12-27 10:52:11"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/2487/"
+"menu_order": 8
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2487
+"menu_item_parent": "2486"
+"object_id": "1536"
+"object": "page"
+"type_label": "Page"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "LBO Mid Cap"
+"status": "publish"
+"name": "LBO Mid Cap"
}
1 => MenuItem {#7729
+children: []
+has_child_class: false
+classes: array:5 [ …5]
+class: "menu-item menu-item-type-post_type menu-item-object-page menu-item-2488"
+level: 1
+post_name: "2488"
+url: "https://www.lbofrance.com/en/lbo-small-cap/"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7025}
#_name: null
#_menu_item_object_id: "1529"
#_menu_item_url: ""
#menu_object: Post {#7730 …63}
+id: 2488
+ID: 2488
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:10 [ …10]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": " "
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": ""
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "post_type"
+"_menu_item_menu_item_parent": "2486"
+"_menu_item_object": "page"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:4 [ …4]
+"post_date_gmt": "2019-12-27 10:52:12"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/2488/"
+"menu_order": 9
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2488
+"menu_item_parent": "2486"
+"object_id": "1529"
+"object": "page"
+"type_label": "Page"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "LBO Small Cap"
+"status": "publish"
+"name": "LBO Small Cap"
}
2 => MenuItem {#7727
+children: []
+has_child_class: false
+classes: array:5 [ …5]
+class: "menu-item menu-item-type-post_type menu-item-object-page menu-item-2489"
+level: 1
+post_name: "2489"
+url: "https://www.lbofrance.com/en/real-estate/"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7025}
#_name: null
#_menu_item_object_id: "1531"
#_menu_item_url: ""
#menu_object: Post {#7728 …63}
+id: 2489
+ID: 2489
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:10 [ …10]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": " "
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": ""
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "post_type"
+"_menu_item_menu_item_parent": "2486"
+"_menu_item_object": "page"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:4 [ …4]
+"post_date_gmt": "2019-12-27 10:52:13"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/2489/"
+"menu_order": 10
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2489
+"menu_item_parent": "2486"
+"object_id": "1531"
+"object": "page"
+"type_label": "Page"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "Real Estate Proptech"
+"status": "publish"
+"name": "Real Estate Proptech"
}
3 => MenuItem {#7725
+children: []
+has_child_class: false
+classes: array:5 [ …5]
+class: "menu-item menu-item-type-post_type menu-item-object-page menu-item-2490"
+level: 1
+post_name: "2490"
+url: "https://www.lbofrance.com/en/venture/"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7025}
#_name: null
#_menu_item_object_id: "1533"
#_menu_item_url: ""
#menu_object: Post {#7726 …63}
+id: 2490
+ID: 2490
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:10 [ …10]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": " "
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": ""
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "post_type"
+"_menu_item_menu_item_parent": "2486"
+"_menu_item_object": "page"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:4 [ …4]
+"post_date_gmt": "2019-12-27 10:52:14"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/2490/"
+"menu_order": 11
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2490
+"menu_item_parent": "2486"
+"object_id": "1533"
+"object": "page"
+"type_label": "Page"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "Venture Digital Health"
+"status": "publish"
+"name": "Venture Digital Health"
}
4 => MenuItem {#7723
+children: []
+has_child_class: false
+classes: array:5 [ …5]
+class: "menu-item menu-item-type-post_type menu-item-object-page menu-item-5374"
+level: 1
+post_name: "5374"
+url: "https://www.lbofrance.com/en/public-equity/"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7025}
#_name: null
#_menu_item_object_id: "5357"
#_menu_item_url: ""
#menu_object: Post {#7724 …63}
+id: 5374
+ID: 5374
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:10 [ …10]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": " "
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": ""
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "post_type"
+"_menu_item_menu_item_parent": "2486"
+"_menu_item_object": "page"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_wp_old_date": array:3 [ …3]
+"_last_translation_edit_mode": "translation-editor"
+"post_date_gmt": "2021-05-21 09:53:35"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
…19
}
]
+has_child_class: true
+classes: array:6 [
0 => ""
1 => "menu-item"
2 => "menu-item-type-custom"
3 => "menu-item-object-custom"
4 => "menu-item-2486"
5 => "menu-item-has-children"
]
+class: "menu-item menu-item-type-custom menu-item-object-custom menu-item-2486 menu-item-has-children"
+level: 0
+post_name: "activites"
+url: "#"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7025}
#_name: null
#_menu_item_object_id: "2486"
#_menu_item_url: "#"
#menu_object: Post {#7732
+ImageClass: "Timber\Image"
+PostClass: "Timber\Post"
+TermClass: "Timber\Term"
+object_type: "post"
+custom: array:10 [ …10]
#___content: null
#_permalink: null
#_next: []
#_prev: []
#_css_class: null
+id: 2486
+ID: 2486
+post_author: "1"
+post_content: ""
+post_date: "2023-03-21 18:25:18"
+post_excerpt: ""
+post_parent: 0
+post_status: "publish"
+post_title: "Expertises"
+post_type: "nav_menu_item"
+slug: "activites"
#__type: null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object_id": "2486"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_menu_item_url": "#"
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:4 [ …4]
+"post_date_gmt": "2019-12-27 10:52:09"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"post_name": "activites"
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/activites/"
+"menu_order": 7
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2486
+"menu_item_parent": "0"
+"object_id": "2486"
+"object": "custom"
+"type_label": "Custom Link"
+"url": "#"
+"target": ""
+"attr_title": ""
+"description": ""
+"classes": array:4 [ …4]
+"xfn": ""
+"current": false
+"current_item_ancestor": false
+"current_item_parent": false
+"__title": "Expertises"
+"status": "publish"
}
+id: 2486
+ID: 2486
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:10 [
"_menu_item_type" => "custom"
"_menu_item_menu_item_parent" => "0"
"_menu_item_object_id" => "2486"
"_menu_item_object" => "custom"
"_menu_item_target" => ""
"_menu_item_classes" => array:1 [ …1]
"_menu_item_xfn" => ""
"_menu_item_url" => "#"
"_last_translation_edit_mode" => "translation-editor"
"_wp_old_date" => array:4 [ …4]
]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": ""
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": "Expertises"
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [
0 => ""
]
+"_menu_item_xfn": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:4 [
0 => "2019-12-27"
1 => "2021-05-21"
2 => "2022-09-09"
3 => "2022-09-12"
]
+"post_date_gmt": "2019-12-27 10:52:09"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/activites/"
+"menu_order": 7
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2486
+"menu_item_parent": "0"
+"object_id": "2486"
+"object": "custom"
+"type_label": "Custom Link"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "Expertises"
+"status": "publish"
+"name": "Expertises"
}
2 => MenuItem {#7721
+children: []
+has_child_class: false
+classes: array:5 [
0 => ""
1 => "menu-item"
2 => "menu-item-type-custom"
3 => "menu-item-object-custom"
4 => "menu-item-2492"
]
+class: "menu-item menu-item-type-custom menu-item-object-custom menu-item-2492"
+level: 0
+post_name: "portefeuille-2"
+url: "https://www.lbofrance.com/en/portfolio/"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7025}
#_name: null
#_menu_item_object_id: "2492"
#_menu_item_url: "https://www.lbofrance.com/en/portfolio/"
#menu_object: Post {#7722
+ImageClass: "Timber\Image"
+PostClass: "Timber\Post"
+TermClass: "Timber\Term"
+object_type: "post"
+custom: array:10 [ …10]
#___content: null
#_permalink: null
#_next: []
#_prev: []
#_css_class: null
+id: 2492
+ID: 2492
+post_author: "1"
+post_content: ""
+post_date: "2023-03-21 18:25:18"
+post_excerpt: ""
+post_parent: 0
+post_status: "publish"
+post_title: "Portfolio"
+post_type: "nav_menu_item"
+slug: "portefeuille-2"
#__type: null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object_id": "2492"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_menu_item_url": "https://www.lbofrance.com/en/portfolio/"
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:4 [ …4]
+"post_date_gmt": "2019-12-27 10:52:17"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"post_name": "portefeuille-2"
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/portefeuille-2/"
+"menu_order": 13
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2492
+"menu_item_parent": "0"
+"object_id": "2492"
+"object": "custom"
+"type_label": "Custom Link"
+"url": "https://www.lbofrance.com/en/portfolio/"
+"target": ""
+"attr_title": ""
+"description": ""
+"classes": array:4 [ …4]
+"xfn": ""
+"current": false
+"current_item_ancestor": false
+"current_item_parent": false
+"__title": "Portfolio"
+"status": "publish"
}
+id: 2492
+ID: 2492
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:10 [
"_menu_item_type" => "custom"
"_menu_item_menu_item_parent" => "0"
"_menu_item_object_id" => "2492"
"_menu_item_object" => "custom"
"_menu_item_target" => ""
"_menu_item_classes" => array:1 [ …1]
"_menu_item_xfn" => ""
"_menu_item_url" => "https://www.lbofrance.com/en/portfolio/"
"_last_translation_edit_mode" => "translation-editor"
"_wp_old_date" => array:4 [ …4]
]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": ""
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": "Portfolio"
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [
0 => ""
]
+"_menu_item_xfn": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:4 [
0 => "2019-12-27"
1 => "2021-05-21"
2 => "2022-09-09"
3 => "2022-09-12"
]
+"post_date_gmt": "2019-12-27 10:52:17"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/portefeuille-2/"
+"menu_order": 13
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2492
+"menu_item_parent": "0"
+"object_id": "2492"
+"object": "custom"
+"type_label": "Custom Link"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "Portfolio"
+"status": "publish"
+"name": "Portfolio"
}
3 => MenuItem {#7719
+children: []
+has_child_class: false
+classes: array:5 [
0 => ""
1 => "menu-item"
2 => "menu-item-type-custom"
3 => "menu-item-object-custom"
4 => "menu-item-2493"
]
+class: "menu-item menu-item-type-custom menu-item-object-custom menu-item-2493"
+level: 0
+post_name: "equipe-2"
+url: "https://www.lbofrance.com/en/team/"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7025}
#_name: null
#_menu_item_object_id: "2493"
#_menu_item_url: "https://www.lbofrance.com/en/team/"
#menu_object: Post {#7720
+ImageClass: "Timber\Image"
+PostClass: "Timber\Post"
+TermClass: "Timber\Term"
+object_type: "post"
+custom: array:10 [ …10]
#___content: null
#_permalink: null
#_next: []
#_prev: []
#_css_class: null
+id: 2493
+ID: 2493
+post_author: "1"
+post_content: ""
+post_date: "2023-03-21 18:25:18"
+post_excerpt: ""
+post_parent: 0
+post_status: "publish"
+post_title: "Team"
+post_type: "nav_menu_item"
+slug: "equipe-2"
#__type: null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object_id": "2493"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_menu_item_url": "https://www.lbofrance.com/en/team/"
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:4 [ …4]
+"post_date_gmt": "2019-12-27 10:52:18"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"post_name": "equipe-2"
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/equipe-2/"
+"menu_order": 14
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2493
+"menu_item_parent": "0"
+"object_id": "2493"
+"object": "custom"
+"type_label": "Custom Link"
+"url": "https://www.lbofrance.com/en/team/"
+"target": ""
+"attr_title": ""
+"description": ""
+"classes": array:4 [ …4]
+"xfn": ""
+"current": false
+"current_item_ancestor": false
+"current_item_parent": false
+"__title": "Team"
+"status": "publish"
}
+id: 2493
+ID: 2493
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:10 [
"_menu_item_type" => "custom"
"_menu_item_menu_item_parent" => "0"
"_menu_item_object_id" => "2493"
"_menu_item_object" => "custom"
"_menu_item_target" => ""
"_menu_item_classes" => array:1 [ …1]
"_menu_item_xfn" => ""
"_menu_item_url" => "https://www.lbofrance.com/en/team/"
"_last_translation_edit_mode" => "translation-editor"
"_wp_old_date" => array:4 [ …4]
]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": ""
+"post_date": "2023-03-21 18:25:18"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": "Team"
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [
0 => ""
]
+"_menu_item_xfn": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:4 [
0 => "2019-12-27"
1 => "2021-05-21"
2 => "2022-09-09"
3 => "2022-09-12"
]
+"post_date_gmt": "2019-12-27 10:52:18"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2023-03-21 18:25:18"
+"post_modified_gmt": "2023-03-21 17:25:18"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/equipe-2/"
+"menu_order": 14
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2493
+"menu_item_parent": "0"
+"object_id": "2493"
+"object": "custom"
+"type_label": "Custom Link"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "Team"
+"status": "publish"
+"name": "Team"
}
]
+id: 73
+ID: 73
+term_id: 73
+name: "Main menu - en"
+title: "Main menu - en"
+options: array:1 [
"depth" => 0
]
+raw_options: []
+theme_location: null
+TermClass: "Term"
+object_type: "term"
+_children: null
+taxonomy: "nav_menu"
+"slug": "main-menu-en"
+"term_group": 0
+"term_taxonomy_id": 73
+"parent": 0
+"count": 14
+"filter": "raw"
+"term_order": "0"
}
"secondary" => Menu {#7081
+MenuItemClass: "Timber\MenuItem"
+PostClass: "Timber\Post"
+depth: 0
+items: array:5 [
0 => MenuItem {#7217
+children: []
+has_child_class: false
+classes: array:6 [
0 => ""
1 => "menu-item"
2 => "menu-item-type-post_type"
3 => "menu-item-object-page"
4 => "current_page_parent"
5 => "menu-item-2494"
]
+class: "menu-item menu-item-type-post_type menu-item-object-page current_page_parent menu-item-2494"
+level: 0
+post_name: "2494"
+url: "https://www.lbofrance.com/en/news-and-press-release/"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7081}
#_name: null
#_menu_item_object_id: "2124"
#_menu_item_url: ""
#menu_object: Post {#7218
+ImageClass: "Timber\Image"
+PostClass: "Timber\Post"
+TermClass: "Timber\Term"
+object_type: "post"
+custom: array:10 [ …10]
#___content: null
#_permalink: null
#_next: []
#_prev: []
#_css_class: null
+id: 2494
+ID: 2494
+post_author: "1"
+post_content: ""
+post_date: "2021-10-14 18:39:04"
+post_excerpt: ""
+post_parent: 0
+post_status: "publish"
+post_title: "News"
+post_type: "nav_menu_item"
+slug: "2494"
#__type: null
+"_menu_item_type": "post_type"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object_id": "2124"
+"_menu_item_object": "page"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_menu_item_url": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:2 [ …2]
+"post_date_gmt": "2019-12-27 10:52:18"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"post_name": "2494"
+"to_ping": ""
+"pinged": ""
+"post_modified": "2021-10-14 18:39:04"
+"post_modified_gmt": "2021-10-14 16:39:04"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/2494/"
+"menu_order": 1
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2494
+"menu_item_parent": "0"
+"object_id": "2124"
+"object": "page"
+"type_label": "Page"
+"url": "https://www.lbofrance.com/en/news-and-press-release/"
+"target": ""
+"attr_title": ""
+"description": ""
+"classes": array:5 [ …5]
+"xfn": ""
+"current": false
+"current_item_ancestor": false
+"current_item_parent": false
+"__title": "News"
+"status": "publish"
}
+id: 2494
+ID: 2494
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:10 [
"_menu_item_type" => "post_type"
"_menu_item_menu_item_parent" => "0"
"_menu_item_object_id" => "2124"
"_menu_item_object" => "page"
"_menu_item_target" => ""
"_menu_item_classes" => array:1 [ …1]
"_menu_item_xfn" => ""
"_menu_item_url" => ""
"_last_translation_edit_mode" => "translation-editor"
"_wp_old_date" => array:2 [ …2]
]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": ""
+"post_date": "2021-10-14 18:39:04"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": "News"
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "post_type"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object": "page"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [
0 => ""
]
+"_menu_item_xfn": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:2 [
0 => "2019-12-27"
1 => "2021-10-13"
]
+"post_date_gmt": "2019-12-27 10:52:18"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2021-10-14 18:39:04"
+"post_modified_gmt": "2021-10-14 16:39:04"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/2494/"
+"menu_order": 1
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2494
+"menu_item_parent": "0"
+"object_id": "2124"
+"object": "page"
+"type_label": "Page"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "News"
+"status": "publish"
+"name": "News"
}
1 => MenuItem {#7219
+children: array:2 [
0 => MenuItem {#7137 …69}
1 => MenuItem {#7140 …69}
]
+has_child_class: true
+classes: array:6 [
0 => ""
1 => "menu-item"
2 => "menu-item-type-custom"
3 => "menu-item-object-custom"
4 => "menu-item-2495"
5 => "menu-item-has-children"
]
+class: "menu-item menu-item-type-custom menu-item-object-custom menu-item-2495 menu-item-has-children"
+level: 0
+post_name: "investisseurs-2"
+url: "#"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7081}
#_name: null
#_menu_item_object_id: "2495"
#_menu_item_url: "#"
#menu_object: Post {#7220
+ImageClass: "Timber\Image"
+PostClass: "Timber\Post"
+TermClass: "Timber\Term"
+object_type: "post"
+custom: array:10 [ …10]
#___content: null
#_permalink: null
#_next: []
#_prev: []
#_css_class: null
+id: 2495
+ID: 2495
+post_author: "1"
+post_content: ""
+post_date: "2021-10-14 18:39:04"
+post_excerpt: ""
+post_parent: 0
+post_status: "publish"
+post_title: "Investors"
+post_type: "nav_menu_item"
+slug: "investisseurs-2"
#__type: null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object_id": "2495"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_menu_item_url": "#"
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:2 [ …2]
+"post_date_gmt": "2019-12-27 10:52:19"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"post_name": "investisseurs-2"
+"to_ping": ""
+"pinged": ""
+"post_modified": "2021-10-14 18:39:04"
+"post_modified_gmt": "2021-10-14 16:39:04"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/investisseurs-2/"
+"menu_order": 2
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2495
+"menu_item_parent": "0"
+"object_id": "2495"
+"object": "custom"
+"type_label": "Custom Link"
+"url": "#"
+"target": ""
+"attr_title": ""
+"description": ""
+"classes": array:4 [ …4]
+"xfn": ""
+"current": false
+"current_item_ancestor": false
+"current_item_parent": false
+"__title": "Investors"
+"status": "publish"
}
+id: 2495
+ID: 2495
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:10 [
"_menu_item_type" => "custom"
"_menu_item_menu_item_parent" => "0"
"_menu_item_object_id" => "2495"
"_menu_item_object" => "custom"
"_menu_item_target" => ""
"_menu_item_classes" => array:1 [ …1]
"_menu_item_xfn" => ""
"_menu_item_url" => "#"
"_last_translation_edit_mode" => "translation-editor"
"_wp_old_date" => array:2 [ …2]
]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": ""
+"post_date": "2021-10-14 18:39:04"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": "Investors"
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "custom"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object": "custom"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [
0 => ""
]
+"_menu_item_xfn": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:2 [
0 => "2019-12-27"
1 => "2021-10-13"
]
+"post_date_gmt": "2019-12-27 10:52:19"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2021-10-14 18:39:04"
+"post_modified_gmt": "2021-10-14 16:39:04"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/investisseurs-2/"
+"menu_order": 2
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2495
+"menu_item_parent": "0"
+"object_id": "2495"
+"object": "custom"
+"type_label": "Custom Link"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "Investors"
+"status": "publish"
+"name": "Investors"
}
2 => MenuItem {#7141
+children: []
+has_child_class: false
+classes: array:5 [
0 => ""
1 => "menu-item"
2 => "menu-item-type-post_type"
3 => "menu-item-object-page"
4 => "menu-item-2498"
]
+class: "menu-item menu-item-type-post_type menu-item-object-page menu-item-2498"
+level: 0
+post_name: "2498"
+url: "https://www.lbofrance.com/en/contact-us/"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7081}
#_name: null
#_menu_item_object_id: "2123"
#_menu_item_url: ""
#menu_object: Post {#7142
+ImageClass: "Timber\Image"
+PostClass: "Timber\Post"
+TermClass: "Timber\Term"
+object_type: "post"
+custom: array:10 [ …10]
#___content: null
#_permalink: null
#_next: []
#_prev: []
#_css_class: null
+id: 2498
+ID: 2498
+post_author: "1"
+post_content: " "
+post_date: "2021-10-14 18:39:05"
+post_excerpt: ""
+post_parent: 0
+post_status: "publish"
+post_title: ""
+post_type: "nav_menu_item"
+slug: "2498"
#__type: null
+"_menu_item_type": "post_type"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object_id": "2123"
+"_menu_item_object": "page"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [ …1]
+"_menu_item_xfn": ""
+"_menu_item_url": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:2 [ …2]
+"post_date_gmt": "2019-12-27 10:52:22"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"post_name": "2498"
+"to_ping": ""
+"pinged": ""
+"post_modified": "2021-10-14 18:39:05"
+"post_modified_gmt": "2021-10-14 16:39:05"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/2498/"
+"menu_order": 5
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2498
+"menu_item_parent": "0"
+"object_id": "2123"
+"object": "page"
+"type_label": "Page"
+"url": "https://www.lbofrance.com/en/contact-us/"
+"target": ""
+"attr_title": ""
+"description": ""
+"classes": array:4 [ …4]
+"xfn": ""
+"current": false
+"current_item_ancestor": false
+"current_item_parent": false
+"__title": "Contact us"
+"status": "publish"
}
+id: 2498
+ID: 2498
+object_type: "post"
+"ImageClass": "Timber\Image"
+"TermClass": "Timber\Term"
+"custom": array:10 [
"_menu_item_type" => "post_type"
"_menu_item_menu_item_parent" => "0"
"_menu_item_object_id" => "2123"
"_menu_item_object" => "page"
"_menu_item_target" => ""
"_menu_item_classes" => array:1 [ …1]
"_menu_item_xfn" => ""
"_menu_item_url" => ""
"_last_translation_edit_mode" => "translation-editor"
"_wp_old_date" => array:2 [ …2]
]
+"___content": null
+"_permalink": null
+"_next": []
+"_prev": []
+"_css_class": null
+"post_author": "1"
+"post_content": " "
+"post_date": "2021-10-14 18:39:05"
+"post_excerpt": ""
+"post_parent": 0
+"post_status": "publish"
+"post_title": ""
+"post_type": "nav_menu_item"
+"__type": null
+"_menu_item_type": "post_type"
+"_menu_item_menu_item_parent": "0"
+"_menu_item_object": "page"
+"_menu_item_target": ""
+"_menu_item_classes": array:1 [
0 => ""
]
+"_menu_item_xfn": ""
+"_last_translation_edit_mode": "translation-editor"
+"_wp_old_date": array:2 [
0 => "2019-12-27"
1 => "2021-10-13"
]
+"post_date_gmt": "2019-12-27 10:52:22"
+"comment_status": "closed"
+"ping_status": "closed"
+"post_password": ""
+"to_ping": ""
+"pinged": ""
+"post_modified": "2021-10-14 18:39:05"
+"post_modified_gmt": "2021-10-14 16:39:05"
+"post_content_filtered": ""
+"guid": "https://www.lbofrance.com/2498/"
+"menu_order": 5
+"post_mime_type": ""
+"comment_count": "0"
+"filter": "raw"
+"db_id": 2498
+"menu_item_parent": "0"
+"object_id": "2123"
+"object": "page"
+"type_label": "Page"
+"target": ""
+"attr_title": ""
+"description": ""
+"xfn": ""
+"__title": "Contact us"
+"status": "publish"
+"name": "Contact us"
}
3 => MenuItem {#7144
+children: []
+has_child_class: false
+classes: array:9 [
0 => "menu-item"
1 => "wpml-ls-slot-5"
2 => "wpml-ls-item"
3 => "wpml-ls-item-fr"
4 => "wpml-ls-menu-item"
5 => "wpml-ls-first-item"
6 => "menu-item-type-wpml_ls_menu_item"
7 => "menu-item-object-wpml_ls_menu_item"
8 => "menu-item-wpml-ls-5-fr"
]
+class: "menu-item wpml-ls-slot-5 wpml-ls-item wpml-ls-item-fr wpml-ls-menu-item wpml-ls-first-item menu-item-type-wpml_ls_menu_item menu-item-object-wpml_ls_menu_item menu-item-wpml-ls-5-fr"
+level: 0
+post_name: null
+url: "https://www.lbofrance.com/lequipe-venture-de-lbo-france-mene-le-tour-de-table-de-23-millions-usd-de-la-societe-antidote/"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7081}
#_name: null
#_menu_item_object_id: null
#_menu_item_url: null
#menu_object: WPML_LS_Menu_Item {#7574
+ID: "wpml-ls-5-fr"
+attr_title: ""
+classes: array:8 [ …8]
+db_id: "wpml-ls-5-fr"
+description: null
+menu_item_parent: 0
+object: "wpml_ls_menu_item"
+object_id: "wpml-ls-5-fr"
+post_parent: null
+post_title: """
\n
<img\n
class="wpml-ls-flag"\n
src="https://www.lbofrance.com/wp-content/plugins/sitepress-multilingual-cms/res/flags/fr.png"\n
alt="fr"\n
\n
\n
/>
"""
+target: null
+type: "wpml_ls_menu_item"
+type_label: null
+url: "https://www.lbofrance.com/lequipe-venture-de-lbo-france-mene-le-tour-de-table-de-23-millions-usd-de-la-societe-antidote/"
+xfn: null
+_invalid: false
+menu_order: 6
+post_type: "nav_menu_item"
+"current": false
+"current_item_ancestor": false
+"current_item_parent": false
+"__title": """
\n
<img\n
class="wpml-ls-flag"\n
src="https://www.lbofrance.com/wp-content/plugins/sitepress-multilingual-cms/res/flags/fr.png"\n
alt="fr"\n
\n
\n
/>
"""
}
+id: null
+ID: "wpml-ls-5-fr"
+object_type: null
+"attr_title": ""
+"db_id": "wpml-ls-5-fr"
+"description": null
+"menu_item_parent": 0
+"object": "wpml_ls_menu_item"
+"object_id": "wpml-ls-5-fr"
+"post_parent": null
+"post_title": """
\n
<img\n
class="wpml-ls-flag"\n
src="https://www.lbofrance.com/wp-content/plugins/sitepress-multilingual-cms/res/flags/fr.png"\n
alt="fr"\n
\n
\n
/>
"""
+"target": null
+"type_label": null
+"xfn": null
+"_invalid": false
+"menu_order": 6
+"post_type": "nav_menu_item"
+"__title": """
\n
<img\n
class="wpml-ls-flag"\n
src="https://www.lbofrance.com/wp-content/plugins/sitepress-multilingual-cms/res/flags/fr.png"\n
alt="fr"\n
\n
\n
/>
"""
+"name": """
\n
<img\n
class="wpml-ls-flag"\n
src="https://www.lbofrance.com/wp-content/plugins/sitepress-multilingual-cms/res/flags/fr.png"\n
alt="fr"\n
\n
\n
/>
"""
}
4 => MenuItem {#7111
+children: []
+has_child_class: false
+classes: array:10 [
0 => "menu-item"
1 => "wpml-ls-slot-5"
2 => "wpml-ls-item"
3 => "wpml-ls-item-en"
4 => "wpml-ls-current-language"
5 => "wpml-ls-menu-item"
6 => "wpml-ls-last-item"
7 => "menu-item-type-wpml_ls_menu_item"
8 => "menu-item-object-wpml_ls_menu_item"
9 => "menu-item-wpml-ls-5-en"
]
+class: "menu-item wpml-ls-slot-5 wpml-ls-item wpml-ls-item-en wpml-ls-current-language wpml-ls-menu-item wpml-ls-last-item menu-item-type-wpml_ls_menu_item menu-item-object-wpml_ls_menu_item menu-item-wpml-ls-5-en"
+level: 0
+post_name: null
+url: "https://www.lbofrance.com/en/lbo-frances-digital-health-team-leads-a-23-million-growth-round-in-antidote/"
+PostClass: "Timber\Post"
+current: false
+current_item_parent: false
+current_item_ancestor: false
#menu: Menu {#7081}
#_name: null
#_menu_item_object_id: null
#_menu_item_url: null
#menu_object: WPML_LS_Menu_Item {#7216
+ID: "wpml-ls-5-en"
+attr_title: ""
+classes: array:9 [ …9]
+db_id: "wpml-ls-5-en"
+description: null
+menu_item_parent: 0
+object: "wpml_ls_menu_item"
+object_id: "wpml-ls-5-en"
+post_parent: null
+post_title: """
\n
<img\n
class="wpml-ls-flag"\n
src="https://www.lbofrance.com/wp-content/plugins/sitepress-multilingual-cms/res/flags/en.png"\n
alt="en"\n
\n
\n
/>
"""
+target: null
+type: "wpml_ls_menu_item"
+type_label: null
+url: "https://www.lbofrance.com/en/lbo-frances-digital-health-team-leads-a-23-million-growth-round-in-antidote/"
+xfn: null
+_invalid: false
+menu_order: 7
+post_type: "nav_menu_item"
+"current": false
+"current_item_ancestor": false
+"current_item_parent": false
+"__title": """
\n
<img\n
class="wpml-ls-flag"\n
src="https://www.lbofrance.com/wp-content/plugins/sitepress-multilingual-cms/res/flags/en.png"\n
alt="en"\n
\n
\n
/>
"""
}
+id: null
+ID: "wpml-ls-5-en"
+object_type: null
+"attr_title": ""
+"db_id": "wpml-ls-5-en"
+"description": null
+"menu_item_parent": 0
+"object": "wpml_ls_menu_item"
+"object_id": "wpml-ls-5-en"
+"post_parent": null
+"post_title": """
\n
<img\n
class="wpml-ls-flag"\n
src="https://www.lbofrance.com/wp-content/plugins/sitepress-multilingual-cms/res/flags/en.png"\n
alt="en"\n
\n
\n
/>
"""
+"target": null
+"type_label": null
+"xfn": null
+"_invalid": false
+"menu_order": 7
+"post_type": "nav_menu_item"
+"__title": """
\n
<img\n
class="wpml-ls-flag"\n
src="https://www.lbofrance.com/wp-content/plugins/sitepress-multilingual-cms/res/flags/en.png"\n
alt="en"\n
\n
\n
/>
"""
+"name": """
\n
<img\n
class="wpml-ls-flag"\n
src="https://www.lbofrance.com/wp-content/plugins/sitepress-multilingual-cms/res/flags/en.png"\n
alt="en"\n
\n
\n
/>
"""
}
]
+id: 74
+ID: 74
+term_id: 74
+name: "Menu secondaire - en"
+title: "Menu secondaire - en"
+options: array:1 [
"depth" => 0
]
+raw_options: []
+theme_location: null
+TermClass: "Term"
+object_type: "term"
+_children: null
+taxonomy: "nav_menu"
+"slug": "menu-secondaire-en"
+"term_group": 0
+"term_taxonomy_id": 74
+"parent": 0
+"count": 6
+"filter": "raw"
+"term_order": "0"
}
"footer" => Menu {#7717
+MenuItemClass: "Timber\MenuItem"
+PostClass: "Timber\Post"
+depth: 0
+items: null
+id: null
+ID: null
+term_id: null
+name: null
+title: null
+options: array:1 [
"depth" => 0
]
+raw_options: []
+theme_location: null
+TermClass: "Term"
+object_type: "term"
+_children: null
+taxonomy: null
}
]
]
Super Globals
$_COOKIE
array:1 [
"wp-wpml_current_language" => "en"
]
$_SERVER
array:46 [
"SERVER_SOFTWARE" => "Apache/2.4.56 (Debian)"
"REQUEST_URI" => "/en/lbo-frances-digital-health-team-leads-a-23-million-growth-round-in-antidote/"
"DOCUMENT_ROOT" => "/var/www/lbofrance.com/docs"
"TMPDIR" => "/tmp"
"TMP" => "/tmp"
"TEMP" => "/tmp"
"PATH" => "/usr/local/sbin:/usr/local/bin:/usr/sbin:/usr/bin:/sbin:/bin"
"HOSTNAME" => "a1c033e8c2ed"
"USER" => "phpuser"
"HOME" => "/var/www"
"SCRIPT_NAME" => "/index.php"
"QUERY_STRING" => ""
"REQUEST_METHOD" => "GET"
"SERVER_PROTOCOL" => "HTTP/1.1"
"GATEWAY_INTERFACE" => "CGI/1.1"
"REDIRECT_URL" => "/en/lbo-frances-digital-health-team-leads-a-23-million-growth-round-in-antidote/"
"REMOTE_PORT" => "32942"
"SCRIPT_FILENAME" => "/var/www/lbofrance.com/docs/index.php"
"SERVER_ADMIN" => "[no address given]"
"CONTEXT_DOCUMENT_ROOT" => "/var/www/lbofrance.com/docs"
"CONTEXT_PREFIX" => ""
"REQUEST_SCHEME" => "https"
"REMOTE_ADDR" => "3.233.219.103"
"SERVER_PORT" => "443"
"SERVER_ADDR" => "192.168.219.15"
"SERVER_NAME" => "www.lbofrance.com"
"SERVER_SIGNATURE" => "<address>Apache/2.4.56 (Debian) Server at www.lbofrance.com Port 443</address>\n"
"HTTP_CONNECTION" => "Keep-Alive"
"HTTP_HOST" => "www.lbofrance.com"
"HTTP_ACCEPT_ENCODING" => "br,gzip"
"HTTP_IF_MODIFIED_SINCE" => "Thu, 11 Aug 2022 14:21:48 GMT"
"HTTP_ACCEPT_LANGUAGE" => "en-US,en;q=0.5"
"HTTP_ACCEPT" => "text/html,application/xhtml+xml,application/xml;q=0.9,*/*;q=0.8"
"HTTP_USER_AGENT" => "CCBot/2.0 (https://commoncrawl.org/faq/)"
"proxy-nokeepalive" => "1"
"SSL_TLS_SNI" => "www.lbofrance.com"
"HTTPS" => "on"
"HTTP_AUTHORIZATION" => ""
"REDIRECT_STATUS" => "200"
"REDIRECT_SSL_TLS_SNI" => "www.lbofrance.com"
"REDIRECT_HTTPS" => "on"
"REDIRECT_HTTP_AUTHORIZATION" => ""
"FCGI_ROLE" => "RESPONDER"
"PHP_SELF" => "/index.php"
"REQUEST_TIME_FLOAT" => 1686115052.2283
"REQUEST_TIME" => 1686115052
]